MCID: CRN139
MIFTS: 60

Cornelia De Lange Syndrome 1 malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Bone diseases, Fetal diseases, Muscle diseases

Aliases & Classifications for Cornelia De Lange Syndrome 1

About this section
Sources:
11Disease Ontology, 12diseasecard, 13DISEASES, 23GeneReviews, 24GeneTests, 25Genetics Home Reference, 27GTR, 30ICD10, 31ICD10 via Orphanet, 37MedGen, 39MeSH, 40MESH via Orphanet, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 52OMIM, 54Orphanet, 62SNOMED-CT, 64The Human Phenotype Ontology, 68UMLS, 69UMLS via Orphanet, 70UniProtKB/Swiss-Prot
See all MalaCards sources

Aliases & Descriptions for Cornelia De Lange Syndrome 1:

Name: Cornelia De Lange Syndrome 1 52 70 27 12
Cornelia De Lange Syndrome 11 23 48 24 25 54 50 13
De Lange Syndrome 11 23 48 24 25 27 39
Brachmann-De Lange Syndrome 23 24 25 54
Cdls 23 48 24 25
 
Bdls 23 24 25
Typus Degenerativus Amstelodamensis 48 25
Brachmann De Lange Syndrome 11 48
Amstelodamensis Typus Degenerativus 70
Cdls1 70

Characteristics:

Orphanet epidemiological data:

54
cornelia de lange syndrome:
Inheritance: Autosomal dominant,Not applicable,X-linked recessive; Prevalence: 1-9/100000 (Europe); Age of onset: Antenatal,Neonatal; Age of death: normal life expectancy

HPO:

64
cornelia de lange syndrome 1:
Inheritance: autosomal dominant inheritance, sporadic
Onset and clinical course: phenotypic variability

GeneReviews:

23
Penetrance: no unaffected individuals with a somatic heterozygous pathogenic variant in nipbl have been reported; thus, penetrance appears to be 100%...


Classifications:



External Ids:

OMIM52 122470
Disease Ontology11 DOID:11725
ICD1030 Q87.1
MeSH39 D003635
NCIt45 C75016
SNOMED-CT62 40354009
Orphanet54 ORPHA199
MESH via Orphanet40 D003635
UMLS via Orphanet69 C0270972
ICD10 via Orphanet31 Q87.1

Summaries for Cornelia De Lange Syndrome 1

About this section
OMIM:52 The Cornelia de Lange syndrome (CDLS) is a multisystem malformation syndrome recognized primarily on the basis of... (122470) more...

MalaCards based summary: Cornelia De Lange Syndrome 1, also known as cornelia de lange syndrome, is related to cornelia de lange syndrome 2 and cornelia de lange syndrome 4, and has symptoms including thin vermilion border, microcephaly and low anterior hairline. An important gene associated with Cornelia De Lange Syndrome 1 is NIPBL (NIPBL, Cohesin Loading Factor), and among its related pathways are Meiosis and SUMOylation. Affiliated tissues include bone, kidney and uterus, and related mouse phenotypes are craniofacial and cellular.

Disease Ontology:11 A genetic disease that is characterized by slow growth before and after birth, intellectual disability that is usually severe to profound, skeletal abnormalities involving the arms and hands, and distinctive facial features.

Genetics Home Reference:25 Cornelia de Lange syndrome is a developmental disorder that affects many parts of the body. The features of this disorder vary widely among affected individuals and range from relatively mild to severe.

NIH Rare Diseases:48 Cornelia de Lange syndrome (CdLS) is a developmental disorder that affects many parts of the body. The severity of the condition and the associated signs and symptoms can vary widely, but may include distinctive facial characteristics, growth delays, intellectual disability and limb defects. Approximately 65% of people affected by CdLS have a change (mutation) in the NIPBL gene. Another 5% of cases are caused by mutations in one of four known genes: SMC1A, SMC3, HDAC8 and RAD21. In the remaining 30% of cases, the underlying genetic cause of the condition is unknown. CdLS can be inherited in an autosomal dominant (NIPBL, SMC2, or RAD21) or X-linked (SMC1A or HDAC8) manner. However, most cases result from new (de novo) mutations and occur in people with no family history of the condition. Treatment is based on the signs and symptoms present in each person. Last updated: 7/27/2015

UniProtKB/Swiss-Prot:70 Cornelia de Lange syndrome 1: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies.

Wikipedia:71 Cornelia de Lange Syndrome (CdLS) is a very rare genetic disorder present from birth, but not always... more...

GeneReviews for NBK1104

Related Diseases for Cornelia De Lange Syndrome 1

About this section

Graphical network of the top 20 diseases related to Cornelia De Lange Syndrome 1:



Diseases related to cornelia de lange syndrome 1

Symptoms & Phenotypes for Cornelia De Lange Syndrome 1

About this section

Symptoms by clinical synopsis from OMIM:

122470

Clinical features from OMIM:

122470

Human phenotypes related to Cornelia De Lange Syndrome 1:

 64 54 (show all 151)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 thin vermilion border64 54 hallmark (90%) Very frequent (99-80%) HP:0000233
2 microcephaly64 54 hallmark (90%) Very frequent (99-80%) HP:0000252
3 low anterior hairline64 54 hallmark (90%) Very frequent (99-80%) HP:0000294
4 long philtrum64 54 hallmark (90%) Very frequent (99-80%) HP:0000343
5 micrognathia64 54 hallmark (90%) Very frequent (99-80%) HP:0000347
6 atresia of the external auditory canal64 54 hallmark (90%) Very frequent (99-80%) HP:0000413
7 anteverted nares64 54 hallmark (90%) Very frequent (99-80%) HP:0000463
8 short neck64 54 hallmark (90%) Very frequent (99-80%) HP:0000470
9 abnormality of the eyelashes64 hallmark (90%) HP:0000499
10 thick eyebrow64 54 hallmark (90%) Very frequent (99-80%) HP:0000574
11 synophrys64 54 hallmark (90%) Very frequent (99-80%) HP:0000664
12 delayed eruption of teeth64 54 hallmark (90%) Very frequent (99-80%) HP:0000684
13 abnormality of the metacarpal bones64 hallmark (90%) HP:0001163
14 hypertonia64 54 hallmark (90%) Very frequent (99-80%) HP:0001276
15 abnormality of the voice64 hallmark (90%) HP:0001608
16 toe syndactyly64 54 hallmark (90%) Very frequent (99-80%) HP:0001770
17 short toe64 hallmark (90%) HP:0001831
18 low posterior hairline64 54 hallmark (90%) Very frequent (99-80%) HP:0002162
19 highly arched eyebrow64 54 hallmark (90%) Very frequent (99-80%) HP:0002553
20 abnormality of calvarial morphology64 hallmark (90%) HP:0002648
21 downturned corners of mouth64 54 hallmark (90%) Very frequent (99-80%) HP:0002714
22 delayed skeletal maturation64 54 hallmark (90%) Very frequent (99-80%) HP:0002750
23 micromelia64 54 hallmark (90%) Very frequent (99-80%) HP:0002983
24 short nose64 54 hallmark (90%) Very frequent (99-80%) HP:0003196
25 short palm64 hallmark (90%) HP:0004279
26 short stature64 54 hallmark (90%) Very frequent (99-80%) HP:0004322
27 depressed nasal bridge64 54 hallmark (90%) Very frequent (99-80%) HP:0005280
28 proximal placement of thumb64 54 hallmark (90%) Very frequent (99-80%) HP:0009623
29 cognitive impairment64 hallmark (90%) HP:0100543
30 multicystic kidney dysplasia64 54 typical (50%) Frequent (79-30%) HP:0000003
31 cryptorchidism64 54 typical (50%) Frequent (79-30%) HP:0000028
32 abnormality of female external genitalia64 typical (50%) HP:0000055
33 vesicoureteral reflux64 54 typical (50%) Frequent (79-30%) HP:0000076
34 low-set, posteriorly rotated ears64 54 typical (50%) Frequent (79-30%) HP:0000368
35 conductive hearing impairment64 54 typical (50%) Frequent (79-30%) HP:0000405
36 sensorineural hearing impairment64 54 typical (50%) Frequent (79-30%) HP:0000407
37 microcornea64 54 typical (50%) Frequent (79-30%) HP:0000482
38 blepharitis64 54 typical (50%) Frequent (79-30%) HP:0000498
39 ptosis64 54 typical (50%) Frequent (79-30%) HP:0000508
40 myopia64 54 typical (50%) Frequent (79-30%) HP:0000545
41 obsessive-compulsive behavior64 54 typical (50%) Frequent (79-30%) HP:0000722
42 single transverse palmar crease64 typical (50%) HP:0000954
43 cutis marmorata64 54 typical (50%) Frequent (79-30%) HP:0000965
44 limitation of joint mobility64 typical (50%) HP:0001376
45 intrauterine growth retardation64 54 typical (50%) Frequent (79-30%) HP:0001511
46 premature birth64 54 typical (50%) Frequent (79-30%) HP:0001622
47 neurological speech impairment64 54 typical (50%) Frequent (79-30%) HP:0002167
48 sleep disturbance64 54 typical (50%) Frequent (79-30%) HP:0002360
49 radioulnar synostosis64 54 typical (50%) Frequent (79-30%) HP:0002974
50 elbow dislocation64 54 typical (50%) Frequent (79-30%) HP:0003042
51 clinodactyly of the 5th finger64 54 typical (50%) Frequent (79-30%) HP:0004209
52 aplasia/hypoplasia of the nipples64 typical (50%) HP:0006709
53 attention deficit hyperactivity disorder64 54 typical (50%) Frequent (79-30%) HP:0007018
54 hypoplasia of penis64 54 typical (50%) Frequent (79-30%) HP:0008736
55 reduced number of teeth64 typical (50%) HP:0009804
56 displacement of the external urethral meatus64 typical (50%) HP:0100627
57 renal insufficiency64 54 occasional (7.5%) Occasional (29-5%) HP:0000083
58 cleft palate64 54 occasional (7.5%) Occasional (29-5%) HP:0000175
59 macrotia64 54 occasional (7.5%) Occasional (29-5%) HP:0000400
60 choanal atresia64 54 occasional (7.5%) Occasional (29-5%) HP:0000453
61 strabismus64 54 occasional (7.5%) Occasional (29-5%) HP:0000486
62 glaucoma64 54 occasional (7.5%) Occasional (29-5%) HP:0000501
63 cataract64 54 occasional (7.5%) Occasional (29-5%) HP:0000518
64 nystagmus64 54 occasional (7.5%) Occasional (29-5%) HP:0000639
65 autism64 54 occasional (7.5%) Occasional (29-5%) HP:0000717
66 pectus excavatum64 54 occasional (7.5%) Occasional (29-5%) HP:0000767
67 congenital diaphragmatic hernia64 54 occasional (7.5%) Occasional (29-5%) HP:0000776
68 primary amenorrhea64 54 occasional (7.5%) Occasional (29-5%) HP:0000786
69 split hand64 occasional (7.5%) HP:0001171
70 seizures64 54 occasional (7.5%) Occasional (29-5%) HP:0001250
71 muscular hypotonia64 54 occasional (7.5%) Occasional (29-5%) HP:0001252
72 prenatal movement abnormality64 54 occasional (7.5%) Occasional (29-5%) HP:0001557
73 ventricular septal defect64 54 occasional (7.5%) Occasional (29-5%) HP:0001629
74 atria septal defect64 occasional (7.5%) HP:0001631
75 talipes64 54 occasional (7.5%) Occasional (29-5%) HP:0001883
76 truncal obesity64 54 occasional (7.5%) Occasional (29-5%) HP:0001956
77 pyloric stenosis64 54 occasional (7.5%) Occasional (29-5%) HP:0002021
78 ventriculomegaly64 54 occasional (7.5%) Occasional (29-5%) HP:0002119
79 cerebral cortical atrophy64 54 occasional (7.5%) Occasional (29-5%) HP:0002120
80 intestinal malrotation64 54 occasional (7.5%) Occasional (29-5%) HP:0002566
81 volvulus64 54 occasional (7.5%) Occasional (29-5%) HP:0002580
82 abnormality of the hip bone64 occasional (7.5%) HP:0003272
83 aplasia/hypoplasia of the cerebellum64 54 occasional (7.5%) Occasional (29-5%) HP:0007360
84 peripheral neuropathy64 54 occasional (7.5%) Occasional (29-5%) HP:0009830
85 increased nuchal translucency64 54 occasional (7.5%) Occasional (29-5%) HP:0010880
86 inguinal hernia64 HP:0000023
87 hypospadias64 54 Frequent (79-30%) HP:0000047
88 hypoplastic male external genitalia64 HP:0000050
89 hypoplastic labia majora64 54 Frequent (79-30%) HP:0000059
90 ectopic kidney64 HP:0000086
91 renal hypoplasia64 HP:0000089
92 proteinuria64 HP:0000093
93 renal cyst64 HP:0000107
94 cleft upper lip64 HP:0000204
95 high palate64 54 Very frequent (99-80%) HP:0000218
96 thin upper lip vermilion64 HP:0000219
97 brachycephaly64 54 Very frequent (99-80%) HP:0000248
98 low-set ears64 HP:0000369
99 astigmatism64 HP:0000483
100 proptosis64 HP:0000520
101 long eyelashes64 54 Very frequent (99-80%) HP:0000527
102 optic nerve coloboma64 HP:0000588
103 optic atrophy64 HP:0000648
104 widely spaced teeth64 54 Very frequent (99-80%) HP:0000687
105 behavioral abnormality64 HP:0000708
106 delayed speech and language development64 HP:0000750
107 short sternum64 HP:0000879
108 hirsutism64 HP:0001007
109 hand oligodactyly64 HP:0001180
110 intellectual disability64 54 Very frequent (99-80%) HP:0001249
111 limited elbow extension64 HP:0001377
112 abnormality of the umbilicus64 HP:0001551
113 weak cry64 HP:0001612
114 thrombocytopenia64 HP:0001873
115 gastroesophageal reflux64 54 Very frequent (99-80%) HP:0002020
116 hiatus hernia64 HP:0002036
117 pneumonia64 HP:0002090
118 hypoplastic nipples64 54 Frequent (79-30%) HP:0002557
119 hypoplasia of the radius64 HP:0002984
120 elbow flexion contracture64 HP:0002987
121 dislocated radial head64 HP:0003083
122 hypoplastic radial head64 HP:0003997
123 2-3 toe syndactyly64 HP:0004691
124 malrotation of colon64 HP:0004785
125 duplication of internal organs64 HP:0005217
126 reduced renal corticomedullary differentiation64 HP:0005565
127 supernumerary ribs64 HP:0005815
128 curly eyelashes64 54 Very frequent (99-80%) HP:0007665
129 phocomelia64 HP:0009829
130 self-injurious behavior64 HP:0100716
131 abnormality of the uterus54 Occasional (29-5%)
132 phthisis bulbi54 Frequent (79-30%)
133 delayed puberty54 Occasional (29-5%)
134 anxiety54 Frequent (79-30%)
135 hip dysplasia54 Occasional (29-5%)
136 joint stiffness54 Frequent (79-30%)
137 failure to thrive54 Frequent (79-30%)
138 defect in the atrial septum54 Occasional (29-5%)
139 short foot54 Very frequent (99-80%)
140 generalized hirsutism54 Very frequent (99-80%)
141 malformation of the heart and great vessels54 Occasional (29-5%)
142 hip dislocation54 Occasional (29-5%)
143 abnormality of the ulna54 Occasional (29-5%)
144 bilateral single transverse palmar creases54 Frequent (79-30%)
145 severe postnatal growth retardation54 Frequent (79-30%)
146 feeding difficulties in infancy54 Frequent (79-30%)
147 short 1st metacarpal54 Very frequent (99-80%)
148 abnormally low-pitched voice54 Very frequent (99-80%)
149 intellectual disability, severe54 Very frequent (99-80%)
150 oligodactyly54 Occasional (29-5%)
151 small hand54 Very frequent (99-80%)

MGI Mouse Phenotypes related to Cornelia De Lange Syndrome 1 according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053829.4HDAC8, KMT2A, MAU2, NIPBL, PDS5A, SHOX2
2MP:00053849.1CTCF, ESCO2, HDAC8, KMT2A, MAU2, NIPBL
3MP:00053788.6ESCO2, HDAC8, KMT2A, MAU2, NIPBL, PAPPA
4MP:00107688.1CTCF, ESCO2, HDAC8, KMT2A, MAU2, NIPBL
5MP:00053908.0HDAC8, KMT2A, MAU2, NIPBL, PAPPA, PDS5A

Drugs & Therapeutics for Cornelia De Lange Syndrome 1

About this section

Drugs for Cornelia De Lange Syndrome 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 103)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Emtricitabineapproved, investigationalPhase 4439143491-57-060877
Synonyms:
(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-.beta.-L-FTC
(-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-2'-Deoxy-5-fluoro-3'-thiacytidine
(-)-FTC
(-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine
(-)-cis-4-amino-5-Fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
(2R-cis)-4-amino-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
.beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine
143491-54-7
143491-57-0
145213-48-5
2',3',5-FTC
2',3'-Dideoxy-5-fluoro-3'-thiacytidine
2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine
2'-Deoxy-5-fluoro-3'-thiacytidine
2-FTC
3'-Thia-2'.3'-dideoxy-5-fluorocytidine
4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one
4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
4-amino-5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine
524W91
AC1L1U3I
AC1Q4KUB
BW 1592
 
BW 524W91
BW-524W91
BW524W91
C122114
C12599
C8H10FN3O3S
CHEBI:31536
CHEMBL885
CID60877
Coviracil
Coviracil(TM)
D01199
DB00879
DRG-0208
Emtricitabin
Emtricitabina
Emtricitabine
Emtricitabine (JAN/USAN/INN)
Emtricitabinum
Emtriva
Emtriva (TN)
Emtriva(TM)
FT-0080009
HMS2089I05
HSDB 7337
LS-135838
LS-173184
NCGC00164564-01
RCV
Racivir
SBB066061
TL8000958
UNII-G70B4ETF4S
ZINC03629271
beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
dOTFC
emtricitabine
2
Stavudineapproved, investigationalPhase 41723056-17-518283
Synonyms:
1-(2,3-Dideoxy-beta-D-glycero-2-pentenofuranosyl)thymine
1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione
1-[5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione & Colony-stimulating factor 2
132425-31-1
2',3' Didehydro 3' deoxythymidine
2',3'-Anhydrothymidine
2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (DDI)
2',3'-Didehydro-2',3'-dideoxythmidine
2',3'-Didehydro-3'-deoxythimidine
2',3'-Didehydro-3'-deoxythymidine
3'- Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor
3'-Deoxy-2',3'-didehydrothymidine
3'-Deoxy-2'-thymidinene
3056-17-5
AC-5263
AC1L2BQ9
AC1Q6BSH
BB_NC-1008
BIDD:GT0082
BMY 27857
BMY-27857
BMY27857
BRN 0618327
Bristol-Myers Brand of Stavudine
Bristol-Myers Squibb Brand of Stavudine
C07312
CHEBI:207119
CHEMBL991
CID18283
CPD000058350
CPD000673569
D 1413
D 4T
D 4T (nucleoside)
D00445
D018119
D1413_SIGMA
D3580
D4T & GM-CSF
D4TMBY-27857-3
DB00649
Dideoxydidehydrothymidine
EU-0100336
Estavudina
Estavudina [INN-Spanish]
FT-0082665
 
HMS2051O20
HSDB 7338
LS-1160
Lopac0_000336
MLS000028546
MLS000759504
MLS001055348
MLS001077292
MolPort-002-507-283
NCGC00023212-03
NCGC00023212-04
NCGC00023212-05
NCGC00023212-07
NCGC00023212-08
NCGC00023212-09
NCGC00023212-10
NSC 163661
NSC163661
SAM001246729
SAM002589948
SMR000058350
SMR000673569
STK801888
STV
Sanilvudine
Sanilvudine (JAN)
Stavudin
Stavudine
Stavudine (USAN/INN)
Stavudine [USAN:BAN:INN]
Stavudine [USAN:INN:BAN]
Stavudine [Usan:Ban:Inn]
Stavudine, Monosodium Salt
Stavudinum
Stavudinum [INN-Latin]
Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)- (7CI,8CI)
UNII-BO9LE4QFZF
ZINC00137884
Zent
Zerit
Zerit (TN)
Zerit XR
Zerit Xr
Zerit(TM)
Zerut XR
d4T
ddeThd
ddeTyd
sanilvudine
stavudine
3
Efavirenzapproved, investigationalPhase 4405154598-52-464139
Synonyms:
(-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(-)-Efavirenz
(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben
(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-chloro-4-Cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one
154598-52-4
1ikv
1ikw
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- (9
6-chloro-4-(2-Cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one
6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
AC-19049
AC1L20IX
BIDD:GT0383
C08088
C14H9ClF3NO2
CHEBI:119486
CHEMBL223228
CID64139
CPD000466351
D00896
DB00625
DB07709
DMP 266
DMP-266
EFV
 
EFZ
Efavirenz
Efavirenz (JAN/INN)
Efavirenzum
Eravirenz
HMS2051J08
HMS2090N16
HSDB 7163
L 743726
L-741211
L-743,726
L-743725
L-743726
LS-173464
MLS000759465
MLS001424087
Met-SDF-1.beta. & Efavirenz
Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz
MolPort-003-983-924
NSC742403
SAM001246667
SBB066062
SMR000466351
Stocrin
Strocin (TM)
Sustiva
Sustiva (TM)
Sustiva (TN)
UNII-JE6H2O27P8
ZINC02020233
efavirenz
efavirenz, (S)-isomer
zoxazin-2-one
Éfavirenz
4
Lamivudineapproved, investigationalPhase 4613134678-17-460825
Synonyms:
(+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(+/-)-3TC
(+/-)-BCH-189
(+/-)-SddC
(-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-2'-Deoxy-3'-thiacytidine
(-)-BCH 189
(-)-BCH-189
(-)-SddC
(-)-beta-L-2',3'-Dideoxy-3'-thiacytidine
(-)NGPB-21
(2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
.beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To
134678-17-4
2',3' Dideoxy 3' thiacytidine
2',3'-Dideoxy-3'-thiacytidine
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA)
3'-Thia-2',3'-dideoxycytidine
3TC
3TC & GNA
3TC & SST
3TC (AIDS INITIATIVE) (AIDS INITIATIVE)
3TC and NV-01
3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine
4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
480434-79-5
AC-1416
AC1L1TZZ
AC1Q6C34
BCH 189
BCH-189
BCH-790
BCH189
BIDD:GT0033
Bio-0652
C07065
C8H11N3O3S
CCRIS 9274
CHEBI:133986
CHEMBL141
CID60825
CPD000466319
D00353
D019259
 
DB00709
DRG-0126
DTHC
Epivir
Epivir (TN)
Epivir(TM)
Epivir-HBV
Epzicom
FT-0082667
GG-714
GR 109714X
GR-109714X
GR109714X
HHA & 3TC
HHA & Lamivudine
HMS2051D21
HSDB 7155
Hepitec
Heptivir
Heptodin
Heptovir
L0217
LMV
LS-2107
Lamivir
Lamivudin
Lamivudina
Lamivudine
Lamivudine & GNA
Lamivudine (JAN/USP/INN)
Lamivudine [USAN:BAN:INN]
Lamivudine [USAN:INN:BAN]
Lamivudine [Usan:Ban:Inn]
Lamivudine, (2S-cis)-Isomer
Lamivudinum
MLS000759424
MLS001424097
MolPort-002-507-347
NCGC00159341-03
NCGC00159341-04
NSC620753
S1706_Selleck
SAM001246582
SAM002589994
SMR000466319
STK801940
UNII-2T8Q726O95
ZINC00012346
Zeffix
Zefix
beta-L-2',3'-Dideoxy-3'-thiacytidine
beta-L-3'-Thia-2',3'-dideoxycytidine
lamivudine
5
Tenofovirapproved, investigationalPhase 4733147127-20-6464205
Synonyms:
(R)-9-(2-Phosphonomethoxypropyl)adenine
(R)-9-(2-Phosphonylmethoxypropyl)adenine
(R)-9-(2-phosphonomethoxypropyl)adenine
(R)-PMPA
147127-20-6
206184-49-8
AC-760
AC1LA9BO
Anh. tenofovir
Anhydrous tenofovir
Apropovir
CHEBI:45809
CHEMBL483
CID464205
D,L-Tenofovir
DB00300
GNA & Tenofovir
GS 1275
GS 1278
GS1278
 
HHA & Tenofovir
KS-5021
MolPort-003-850-411
NCGC00167535-01
PMPA
PMPA-(R)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI)
Phosphonic acid, [[2-(6-amino-9H-purin-9
S1401_Selleck
TDF
TFV
Tenefovir
Tenofovir
Tenofovir (anh.)
Tenofovir disoproxil
Tenofovir disoproxil fumarate
UNII-99YXE507IL
Viread
Viread, Tenofovir
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
6
ZidovudineapprovedPhase 449430516-87-135370
Synonyms:
-Azido-3&prime
-deoxythymidine
1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine
3&prime
3' Azido 2',3' Dideoxythymidine
3' Azido 3' deoxythymidine
3'-Azido-2',3'-Dideoxythymidine
3'-Azido-3'-deoxythymidine
3'-Azido-3'-deoxythymidine & Concanavalin A
3'-Azido-3'-deoxythymidine & Erythropoietin
3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19
3'-Azido-3'-deoxythymidine & Interleukin-1
3'-Azido-3'-deoxythymidine & Interleukin-2
3'-Azido-3'-deoxythymidine & Interleukin-6
3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6
3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon
3'-Azido-3'-deoxythymidine & Sho-Saiko-To
3'-Azido-3'-deoxythymidine (AIDS)
3'-Azido-3'deoxythymidine & Interferon .alpha.
3'-Azidothymidine
3'-Deoxy-3'-azidothymidine
3'-azido-3'-deoxythymidine, AZT
3-Azido-3-deoxythymidine
30516-87-1
399024-19-2
A2169_SIGMA
AC1L1TKL
AC1Q2OEK
AZT
AZT & CD4(178)-PE 40
AZT & Colony-stimulating factor 2
AZT & Concanavalin A (ConA)
AZT & EPO
AZT & GM-CSF
AZT & HPA
AZT & IFN.alpha.
AZT & IL-1
AZT & IL-2
AZT & IL-6
AZT & Interferon-.alpha.-2
AZT & Li & EPO
AZT & Li & GM-CSF
AZT & Li & IL-1
AZT & Li & IL-6
AZT & Lymphoblastoid Interferon
AZT & NP (from PHCA or HSA)
AZT & PM-19
AZT & SST
AZT & rIFN.alpha.2
AZT & rsCD4 & rIFN.alpha.A
AZT & rsT4
AZT & sCD4
AZT & srCD4
AZT (Antiviral)
AZT Antiviral
AZT TRANSPLACENTAL CARCINOGENESIS STUDY
AZT+PRO 140
AZT, Antiviral
Antiviral AZT
Apo-Zidovudine
Azidothymidine
Aztec
BB_NC-1012
BPBio1_000403
BRD-K72903603-001-04-6
BSPBio_000365
BSPBio_003153
BW A509U
BW-A 509U
BW-A-509U
BW-A509U
BWA 509U
BWA-509U
BWA509U
C07210
CCRIS 105
CHEBI:10110
CHEBI:127307
CHEMBL129
CID35370
 
CPD000058351
Compound S
Cpd S
D00413
D015215
DB00495
DRG-0004
DS-4152 & AZT
DivK1c_000524
HMS1921J20
HMS2090G11
HMS2092D06
HMS501K06
HSDB 6515
IDI1_000524
Interferon AD + 3'-azido-3'-deoxythymidine
Intron A & AZT
K7 [P Ti2 W10 O40]
KBio1_000524
KBio2_001828
KBio2_004396
KBio2_006964
KBio3_002653
KBioGR_000703
KBioSS_001828
LS-1159
Liposomal AZT-SN-1
Liposomal AZT-SN-3
MLS000028548
MLS001055351
MLS001076358
MLS002153202
MLS002222249
Met-SDF-1.beta. & AZT
Met-SDF-1.beta. & Zidovudine
MolPort-002-507-286
NCGC00023945-03
NCGC00023945-04
NCGC00023945-05
NCGC00023945-08
NCGC00178237-01
NCGC00178237-02
NINDS_000524
NSC 602670
Novo-Azt
PC-SOD+AZT
Prestwick3_000333
Propolis+AZT
Racemic Liposomal AZT
Retrovir
Retrovir (TN)
Retrovir(TM)
SAM002548971
SMR000058351
SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SPBio_000834
SPECTRUM1502109
STK801891
Spectrum2_000927
Spectrum3_001507
Spectrum4_000332
Spectrum5_001101
Spectrum_001348
UNII-4B9XT59T7S
ZDV
ZIDOVUDINE [AZT]
ZINC03779042
ZVD
Zidovudin
Zidovudina
Zidovudina [Spanish]
Zidovudine (JAN/USP/INN)
Zidovudine EP III
Zidovudine [USAN:INN:BAN:JAN]
Zidovudine+PRO 140
Zidovudinum
Zidovudinum [Latin]
antiviral
azidodeoxythymidine
rIFN-beta seron & AZT
racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
zidovudin
zidovudine
7
Progesteroneapproved, vet_approvedPhase 4, Phase 253757-83-05994
Synonyms:
(S)-4-Pregnene-3,20-dione
(S)-Pregn-4-en-3,20-dione
(S)-Progesterone
.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Progesterone
17a-Progesterone
17alpha-Progesterone
17alpha-progesterone
17α-progesterone
1dbb
1h60
257630-50-5
3,20-Pregnene-4
32104FB6-BF81-4F6E-83C2-024DEEAEB272
4-Pregnen-3,20-dione
4-Pregnene-3,20-dione
46665_FLUKA
46665_RIEDEL
57-83-0
753497-20-0
8012-32-6
8023-13-0
AC-700
AC1L1LKF
AI3-51682
Agolutin
Akrolutin
BB_NC-0185
BHR-100
BIDD:ER0547
BIDD:PXR0094
BPBio1_000676
BRD-K64994968-001-03-6
BSPBio_000614
Bio-luton
C00410
CCRIS 533
CHEBI:17026
CHEMBL103
CID5994
CIDR
CMC_13406
COL-1620
CPD000058345
Colprosterone
Corlutin
Corlutina
Corluvite
Corporin
Corpus Luteum Hormone
Corpus luteum hormone
Crinone
Crinone (TN)
Crinone progesterone gel
Curretab
Cyclogest
Cyclogesterin
D00066
D4-Pregnene-3,20-dione
DB00396
DR-2011
Delalutin
Delta(4)-pregnene-3,20-dione
Duraprogen
EINECS 200-350-6
ETI-411
EU-0100895
Endometrin
Estima
FE-999913
Flavolutan
Fologenon
Gelbkoerperhormon
Gesterol
Gesterol 100
Gesterol 50
Gestiron
Gestone
Gestormone
Gestron
Glanducorpin
Gynlutin
Gynoluton
Gynolutone
HMS1569O16
HMS2051O05
HMS2090J07
HSDB 3389
Hormoflaveine
Hormoluton
Hydroxyprogesterone Caproate
Hydroxyprogesterone Caproic acid
LMST02030159
LS-234
Lingusorbs
Lipo-Lutin
Lipolutin
Lopac0_000895
Lucorteum
Lucorteum Sol
Lucorteum sol
Lugesteron
Luteal hormone
Luteinique
Luteocrin normale
Luteodyn
Luteogan
Luteohormone
Luteol
Luteol (VAN)
Luteopur
Luteosan
Luteostab
Luteovis
Luteum
Lutex
Lutidon
Lutin
Lutinus
Lutociclina
Lutocuclin M
Lutocyclin
Lutocyclin M
 
Lutocyclin m
Lutocylin
Lutocylol
Lutoform
Lutogyl
Lutogynon
Lutren
Lutromone
MLS000028517
MLS000758277
MLS001074187
MLS002222367
MPA
Membrettes
Methylpregnone
Micronized Progesterone
MolPort-001-794-643
NCGC00022185-03
NCGC00022185-04
NCGC00022185-05
NCGC00022185-06
NCGC00022185-07
NCGC00022185-08
NCGC00022185-09
NCGC00090798-01
NCGC00090798-02
NCI60_042166
NSC 64377
NSC 9704
NSC-9704
NSC64377
NSC9704
Nalutron
Natural Progesterone
P 0130
P0130_SIGMA
P0478
P3972_SIGMA
P6149_SIGMA
P7556_ALDRICH
P7556_SIGMA
P8783_SIGMA
P9776_SIGMA
PROGESTERONE
Percutacrine
Percutacrine Luteinique
Piaponon
Pranone
Pregn-4-en-3,20-dione
Pregn-4-ene-3,20-dione
Pregnene-3,20-dione
Pregnenedione
Prestwick0_000477
Prestwick1_000477
Prestwick2_000477
Prestwick3_000477
Prestwick_411
Primolut
Prochieve
Progeffik
Progekan
Progestan
Progestasert
Progesterol
Progesteron
Progesterona
Progesterona [INN-Spanish]
Progesterone
Progesterone (JP15/USP/INN)
Progesterone [INN:BAN:JAN]
Progesterone [Progestins]
Progesterone, water-soluble
Progesterone-Water Soluble
Progesterone: HBC complex
Progesteronum
Progesteronum [INN-Latin]
Progestin
Progestogel
Progestol
Progeston
Progestone
Progestosol
Progestrel
Progestron
Progestronol
Progestérone
Projestaject
Prolets
Prolidon
Prolutin
Proluton
Prolutone
Prometrium
Prometrium (TN)
Prontogest
Protormone
S00293
S1705_Selleck
SAM001247039
SMR000058345
SMR000653542
SPBio_002553
SR-01000000088
SR-01000000088-5
Spectrum5_002053
Syngesterone
Syngestrets
Synovex S
Syntolutan
U 3672
UNII-4G7DS2Q64Y
Utrogest
Utrogestan
Vitarrine
WLN: L E5 B666 OV MUTJ A1 E1 FV1
ZINC04428529
beta-Progesterone
bmse000482
component of Cyclogesterin
corpus luteum hormone
delta(4)-Pregnene-3,20-dione
delta(Sup 4)-Pregnene-3,20-dione
delta(Sup4)-pregnene-3,20-dione
delta(sup 4)-Pregnene-3,20-dione
delta4-Pregnene-3,20-dione
luteohormone
nchembio.2007.53-comp14
8
IbutilideapprovedPhase 4, Phase 25122647-32-9, 122647-31-860753
Synonyms:
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfoanilide (E)-2-butenedioate (2:1)
(+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfonanilide fumarate (2:1) (salt)
(+-)-N-(4-(4-(Ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide (E)-butenedioate
(E)-but-2-enedioic acid
122647-31-8
122647-31-8 (Parent)
122647-32-9
122647-32-9 (Fumarate)
130350-52-6
2C20H36N2O3S.C4H4O4
AC1L1TUW
AC1NQXZ2
AC1O5NJM
AC1Q6VUF
Butilide fumarate
C07753
C20H36N2O3S
CHEBI:112608
CHEMBL1200564
CHEMBL533
CID5281065
CID60753
CID6437366
Corvert
Corvert (TN)
D00648
D08060
DB00308
I06-1701
IBUTILIDE FUMARATE
Ibutilid
 
Ibutilida
Ibutilida [INN-Spanish]
Ibutilide
Ibutilide (INN)
Ibutilide Fumarate
Ibutilide Fumarate [USAN]
Ibutilide [BAN:INN]
Ibutilide [INN:BAN]
Ibutilide fumarate (USAN)
Ibutilidum
Ibutilidum [INN-Latin]
LS-172765
LS-90123
LS-90124
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-, (E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (+-)-,(E)-2-butenedioate (2:1) (salt)
Methanesulfonamide, N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)-, (E)-2-butenedioate (2:1) (salt)
MolPort-005-932-621
N-(4-(4-(ethylheptylamino)-1-hydroxybutyl)phenyl)methanesulfonamide
N-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide
N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide
NCGC00181771-01
U 70226E
U-70226E
U-82208E
U-82209E
U82208E
U82209E
UNII-2436VX1U9B
UNII-9L5X4M5L6I
ibutilide, (+-)-isomer
ibutilide, fumarate salt (2:1), (+-)-isomer
n-(4-{4-[ethyl(heptyl)amino]-1-hydroxybutyl}phenyl)methanesulfonamide
9
NevirapineapprovedPhase 4222129618-40-24463
Synonyms:
11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody)
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
129618-40-2
1vrt
2hny
AC-643
AC1L1I81
BI RG 587
BI-RG-587
BI-RG-587 & CD4-IgG
BIDD:GT0326
BIRG 0587
BIRG 587
BIRG-0587
BIRG-587
BIRG587
Bio-0789
C07263
C15H14N4O
CHEBI:44659
CHEMBL57
CID4463
CPD000048458
Cahill May Roberts Brand of Nevirapine
D00435
D019829
DB00238
DB08311
 
HMS2051J09
HSDB 7164
I02-0310
LS-2289
MLS000084585
MLS000759409
MLS001055309
MLS001201730
MolPort-002-507-817
N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin
NCGC00065890-02
NEV
NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE
NSC 641530
NSC641530
NVP
Nevirapine
Nevirapine & CD4-IgG
Nevirapine & PRO 140
Nevirapine (JAN/USP/INN)
Nevirapine [USAN:INN]
Promeco Brand of Nevirapine
S1742_Selleck
SAM001246551
SMR000048458
STK580320
UNII-99DK7FVK1H
Viramune
Viramune (TN)
Viramune(TM)
Viramune, BI-RG 587, Nevirapine
ZINC00004778
nevirapine
10
Testosteroneapproved, investigationalPhase 454658-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
 
Intrinsa
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Hydrate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
11
MethyltestosteroneapprovedPhase 454658-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
 
17beta-Hydroxy-17-methylandrost-4-en-3-one
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Virilon
12
Pyridoxineapproved, nutraceutical, vet_approvedPhase 418665-23-61054
Synonyms:
(5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate
12001-78-4
2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin [German]
2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine
2-methyl-3-hydroxy-4,5-bis(hydroxy-methyl) pyridine
2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-methyl-4,5-dimethylol-pyridin-3-ol
2B3E07D2-E4CC-4CC5-B085-6070BA01F9F0
3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-, hydrochloride
3-Hydroxy-2-Picoline-4,5-dimethanol
3-Hydroxy-4,5-dihydroxymethyl-2-methylpyridine hydrochloride
3-Hydroxy-4,5-dimethylol-.alpha.-picoline hydrochloride
3-Hydroxy-4,5-dimethylol-alpha-picoline
3-Hydroxy-4,5-dimethylol-alpha-picoline hydrochloride
3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine
4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol
4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol hydrochloride
4,5-bis(hydroxymethyl)-2-methyl-3-pyridinol hydrochloride
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol
4,5-bis(hydroxymethyl)-2-methylpyridine-3-ol
4-Deoxypyridoxine 5'-phosphate
47862_SUPELCO
5-Hydroxy-6-methyl-3,4-pyridinedicarbinol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol
5-Hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol, hydrochloride
58-56-0
58-56-0 (HCL)
58-56-0 (hydrochloride)
65-23-6
65-23-6 (Parent)
8059-24-3
85078-23-5
AC-12024
AC-14512
AC-907/25014218
AC1L1AMH
AC1L1LMI
AC1L2XK2
AC1Q22HP
AC1Q2G66
AC1Q3F63
AI3-19016
AIDS-006784
AIDS006784
AR-1A6363
AR-1J1632
Adermin hydrochloride
Adermine
Adermine hydrochloride
Aderomine hydrochloride
Aderoxin
Aderoxine
Alestrol
BB_NC-0050
BIDD:PXR0180
BPBio1_000646
BSPBio_000586
Becilan
Beesix
Benadon
Bonasanit
C00314
C8H11NO3
CAS-58-56-0
CBDivE_015627
CCRIS 1903
CHEBI:16709
CHEBI:30961
CHEMBL1200756
CHEMBL1364
CID104817
CID1054
CID6019
CPD0-1221
Campoviton 6
Cernevit-12
D02179
D025101
D08454
DB00165
EINECS 200-386-2
EINECS 200-603-0
EINECS 232-503-8
Godabion
Gravidox
HMS1569N08
HMS2093L07
HSDB 1212
Hexa-Betalin
Hexa-Betalin (R)
Hexa-betalin (TN)
Hexabetalin
Hexabione hydrochloride
 
Hexavibex
Hexermin
Hexermine
Hexobion
Hydoxin
I02-1897
I02-2297
KST-1A8556
LS-134393
LS-187072
LS-2332
MLS001074329
MLS002153915
MolPort-002-137-856
MolPort-002-319-991
MolPort-005-933-330
NCGC00016261-01
NCGC00164317-01
NCGC00180946-01
NSC 36225
NSC36225
NSC36225 (HCL)
Nestrex
Oprea1_061614
P0561
P4722_SIAL
P5669_SIGMA
P6280_SIGMA
P8666_SIGMA
P9755_SIAL
PN
PN HCl
PYRIDOXINE HYDROCHLORIDE
PYRIDOXINE HYDROCHLORIDE, U.S.P.
Paxadon
Piridossina
Piridossina [DCIT]
Piridoxina
Piridoxina [INN-Spanish]
Prestwick0_000623
Prestwick1_000623
Prestwick2_000623
Prestwick3_000623
Prestwick_925
Pydox
Pyridipca
Pyridox
Pyridoxin
Pyridoxin hydrochloride
Pyridoxine
Pyridoxine (INN)
Pyridoxine HCl
Pyridoxine Hydrochloride (B6)
Pyridoxine [INN:BAN]
Pyridoxine chloride
Pyridoxine hydrochloride (JP15/USP)
Pyridoxine hydrochloride [USAN:JAN]
Pyridoxine hydrogen chloride
Pyridoxine monohydrochloride
Pyridoxine, hydrochloride
Pyridoxine-HCl Microencapsulated
Pyridoxinium chloride
Pyridoxinum
Pyridoxinum [INN-Latin]
Pyridoxinum hydrochloricum
Pyridoxinum hydrochloricum (Hungarian)
Pyridoxol
Pyridoxol hydrochloride
Pyridoxol, hydrochloride
Pyridoxolum
Rodex
Rodex (R)
Rodex TD
SMP2_000230
SMR000674613
SPBio_002805
STK177324
STOCK1N-08684
Spondylonal
Tex Six T.R.
TimTec1_000657
UNII-68Y4CF58BV
UNII-KV2JZ1BI6Z
Vitamin B 6
Vitamin B6
Vitamin B6-hydrochloride
Vitamin V6
Vitamin V6 (TN)
Vitamin-?B6
Vitamin-?B6 hydrochloride
Vitaped
WLN: T6NJ B1 CQ D1Q E1Q &GH
ZINC00049154
ZINC21983293
bmse000288
c1302
component of Alestrol
nchembio.93-comp1
pyridoxine
vitamin B6
13
Pyridoxalapproved, nutraceuticalPhase 418566-72-81050
Synonyms:
2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine
3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde
 
3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde
3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
Piridoxal
Pyridoxal
Pyridoxaldehyde
14Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 212767
15HormonesPhase 4, Phase 3, Phase 213979
16Anti-Retroviral AgentsPhase 4, Phase 3, Phase 23232
17Anti-HIV AgentsPhase 4, Phase 3, Phase 23100
18Anti-Infective AgentsPhase 4, Phase 3, Phase 221402
19ProgestinsPhase 4, Phase 2546
20AntimetabolitesPhase 4, Phase 311774
21Hormone AntagonistsPhase 4, Phase 3, Phase 212778
22Antineoplastic Agents, HormonalPhase 4, Phase 35407
23Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 23822
24Reverse Transcriptase InhibitorsPhase 41880
25Cytochrome P-450 CYP3A InducersPhase 41101
26Cytochrome P-450 CYP2C9 InhibitorsPhase 4658
27Anti-Arrhythmia AgentsPhase 4, Phase 2, Phase 32969
28Antiviral AgentsPhase 4, Phase 3, Phase 29732
29Nucleic Acid Synthesis InhibitorsPhase 4, Phase 34855
30Testosterone undecanoatePhase 4546
31
Testosterone enanthatePhase 4546315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
32Anabolic AgentsPhase 4499
33AndrogensPhase 41275
34Testosterone 17 beta-cypionatePhase 4546
35Vitamin B 6Phase 4186
36
DaunorubicinapprovedPhase 326420830-81-330323
Synonyms:
(+)-Daunomycin
(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside
(7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione
(8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro--6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
11006-54-5
11048-29-6
1407-15-4
149541-57-1
20830-81-3
23942-76-9
27576-81-4
28020-80-6
AB00514669
AC1L1JCP
AC1Q29OI
AI3-52942
Acetyladriamycin
Anthracyline
Antibiotics From Streptomyces Coeruleorubidus
Antibiotics from Streptomyces coeruleorubidus
BPBio1_000389
BRD-K43389675-003-02-7
BRN 1445583
BSPBio_000353
C01907
CCRIS 914
CHEBI:41977
CHEMBL178
CID30323
Cerubidin
Cerubidine
D07776
DAUNORUBICIN HCL
DB00694
DM1
Daunamycin
Daunarubicinum
Dauno-Rubidomycine
DaunoXome
DaunoXome (TN)
Daunoblastin
Daunoblastine
Daunomycin
 
Daunomycin Hydrochloride
Daunomycin, Hydrochloride
Daunorrubicina
Daunorubicin
Daunorubicin (INN)
Daunorubicin (liposomal)
Daunorubicin Hcl
Daunorubicin Hydrochloride
Daunorubicin [INN:BAN]
Daunorubicin, Hydrochloride
Daunorubicina
Daunorubicine
Daunorubicinum
Daunorubicinum [INN-Latin]
Daunoxome
EINECS 244-069-7
FI 6339
FI6339
HMS2089H04
HMS2091K06
HSDB 5095
LMPK13050002
LS-187381
LS-997
Leukaemomycin C
MolPort-002-533-961
NCGC00024246-05
NCGC00024246-06
NCGC00025173-01
NCI-C04693
NChemBio.2007.10-comp14
NSC 83142
NSC-82151
Ondena
Prestwick3_000487
RCRA waste no. U059
RP 13057
Rcra Waste No. U059
Rp 13057 Hydrochloride
Rubidomycin
Rubidomycin Hydrochloride
Rubomycin
Rubomycin C
Tocris-1467
UNII-ZS7284E0ZP
VS-103
daunorubicin
nchembio723-comp2
37
Dexamethasoneapproved, investigational, vet_approvedPhase 3208450-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
 
Dexameth
Dexamethansone
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
38
EtoposideapprovedPhase 3123233419-42-036462
Synonyms:
(-)-Etoposide
121471-01-0
136598-18-0
201594-04-9
33419-42-0
35317-32-9
4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside
4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin
4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside
4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside
51854-34-3
76576-58-4
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one
AB00438905
AC1L1FN8
AC1L1VT3
AC1L6246
AC1NR4OG
AC1O4WGG
AC1O7M1N
AC1Q47JJ
Ambap33419-42-0
BPBio1_000673
BRD-K37798499-001-02-5
BSPBio_000611
Bio1_000489
Bio1_000978
Bio1_001467
C01576
CCRIS 2392
CHEBI:4911
CHEBI:588795
CHEMBL44657
CID11758093
CID284997
CID3310
CID36462
CID5284558
CID6419930
CID6610299
CPD000112002
D00125
DB00773
DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE,
Demethyl Epipodophyllotoxin Ethylidine Glucoside
Demethyl-epiodophyllotoxin ethylidene glucoside
Demethylepipodophyllotoxin-beta-D-ethylideneglucoside
E0675
E1383_SIGMA
EINECS 251-509-1
EPE
EPEG
ETOP
Epipodophyllotoxin
Epipodophyllotoxin VP-16213
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
Eposide
Eposin
 
Eposin, Vepesid, VP-16, Toposar, Etoposide
Etopol
Etopophos
Etopophos (phosphate salt)
Etoposid
Etoposide
Etoposide (JP15/USP/INN)
Etoposide (VP16)
Etoposide [USAN:INN:BAN:JAN]
Etoposido
Etoposido [INN-Spanish]
Etoposidum
Etoposidum [INN-Latin]
Etosid
HMS1569O13
HMS2052N05
HMS2089F14
HSDB 6517
I06-0248
KBioSS_002410
LS-1214
Lastet
MLS000049957
MLS001074951
MLS001424283
MLS002153463
MLS002207239
MLS002222184
MolPort-003-983-431
MolPort-004-905-001
MolPort-004-955-161
NCGC00025056-02
NChemBio.2007.10-comp19
NK 171
NSC 141540
NSC-141540
NSC141540
Prestwick0_000396
Prestwick1_000396
Prestwick2_000396
Prestwick3_000396
Prestwick_211
S1225_Selleck
SAM001246880
SMR000112002
SPBio_002532
ST056353
Toposar
UNII-6PLQ3CP4P3
VP 16
VP 16 (pharmaceutical)
VP 16-213
VP 16213
VP-16
VP-16-213
VePESID (TN)
VePesid
Vepesid
Vepesid J
Vepeside
ZINC03830818
ZINC03938684
Zuyeyidal
etoposide
nchembio.573-comp8
nchembio873-comp2
trans-Etoposide
39
Cyclophosphamideapproved, investigationalPhase 3282950-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Anhydrous cyclophosphamide
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
 
DB00531
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide
40
Busulfanapproved, investigationalPhase 354055-98-12478
Synonyms:
1, 4-Dimethanesulfonoxybutane
1, 4-Dimethylsulfonoxybutane
1, {4-Bis[methanesulfonoxy]butane}
1,4-BUTANEDIOL DIMETHANESULFONATE
1,4-Bis(methanesulfonoxy)butane
1,4-Bis(methanesulfonyloxy)butane
1,4-Bis[methanesulfonoxy]butane
1,4-Butanedi yl dimethanesulfonate
1,4-Butanediol dimethanesulfonate
1,4-Butanediol dimethanesulphonate
1,4-Butanediol dimethylsulfonate
1,4-Butanediol, dimethanesulfonate
1,4-Butanediol, dimethanesulphonate
1,4-Butanediyl dimethanesulfonate
1,4-Di(methylsulfonoxy)butane
1,4-Dimesyloxybutane
1,4-Dimethane sulfonyl oxybutane
1,4-Dimethanesulfonoxybutane
1,4-Dimethanesulfonoxylbutane
1,4-Dimethanesulfonyloxybutane
1,4-Dimethanesulphonyloxybutane
1,4-Dimethylsulfonoxybutane
1,4-Dimethylsulfonyloxybutane
2041 C. B
2041 C. B.
2041 C.B
2041 C.B.
4-((Methylsulfonyl)oxy)butyl methanesulfonate
4-methylsulfonyloxybutyl methanesulfonate
55-98-1
AC-198
AC1L1DRQ
AC1Q4GRQ
AI3-25012
AKOS003614975
AN 33501
Ambap55-98-1
B1022
B2635_FLUKA
B2635_SIGMA
BRN 1791786
BSPBio_001920
BUSULFAN (1,4-BUTANEDIOL, DIMETHANESULFONATE)
Bisulfex
Busilvex
Busulfan
Busulfan (JP15/USP/INN)
Busulfan GlaxoSmithKline Brand
Busulfan Orphan Brand
Busulfan Wellcome
Busulfan Wellcome Brand
Busulfan [INN:JAN]
Busulfano
Busulfano [INN-Spanish]
Busulfanum
Busulfanum [INN-Latin]
Busulfex
Busulphan
Busulphane
Butanedioldimethanesulfonate
Buzulfan
C.B. 2041
C6H14O6S2
CB 2041
CCRIS 418
CHEBI:28901
CHEMBL820
CID2478
CPD000058613
Citosulfan
D002066
D00248
DB01008
DivK1c_000847
EINECS 200-250-2
FT-0083567
G.T. 41
GT 2041
GT 41
Glaxo Wellcome Brand of Busulfan
GlaxoSmithKline Brand of Busulfan
Glyzophrol
HMS1920I07
HMS2091O09
HMS502K09
 
HSDB 7605
I09-1371
IDI1_000847
InChI=1/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3
KBio1_000847
KBio2_000512
KBio2_003080
KBio2_005648
KBio3_001420
KBioGR_000698
KBioSS_000512
LS-1358
Leucosulfan
MLS001076666
MYLERAN (TN)
Mablin
Methanesulfonic
Methanesulfonic acid, tetram ethylene ester
Methanesulfonic acid, tetramethylene ester
Mielevcin
Mielosan
Mielucin
Milecitan
Mileran
Misulban
Mitosan
Mitostan
MolPort-001-783-406
Myeleukon
Myeloleukon
Myelosan
Myelosanum
Mylecytan
Myleran
Myleran Tablets
Myleran tablets
Myleran, Busulfex, Busulfan
Mylerlan
NCGC00090905-01
NCGC00090905-02
NCGC00090905-03
NCGC00090905-04
NCGC00090905-05
NCGC00090905-06
NCGC00090905-07
NCI-C01592
NCI60_041640
NCIMech_000192
NINDS_000847
NSC 750
NSC-750
NSC-750sulphabutin
NSC750
Orphan Brand of Busulfan
Prestwick_989
S1692_Selleck
SAM002554887
SMR000058613
SPBio_000253
SPECTRUM1500152
ST50825921
Spectrum2_000067
Spectrum3_000320
Spectrum4_000259
Spectrum5_000928
Spectrum_000092
Sulfabutin
Sulfabutin (VAN)
Sulphabutin
Tetramethylene Dimethane Sulfonate
Tetramethylene bis(methanesulfonate)
Tetramethylene bis[methanesulfonate]
Tetramethylene dimethane sulfonate
Tetramethylene {bis[methanesulfonate]}
Tetramethylenester Kyseliny Methansulfonove
Tetramethylenester kyseliny methansulfonove
Tetramethylenester kyseliny methansulfonove [Czech]
UNII-G1LN9045DK
WLN: WS1&O4OSW1
Wellcome Brand of Busulfan
Wellcome, Busulfan
X 149
acid, tetramethylene ester
alkylating agent: crosslinks guanine residues
busulfan
butane-1,4-diyl dimethanesulfonate
n-Butane-1,3-di(methylsulfonate)
41
FludarabineapprovedPhase 3111321679-14-1, 75607-67-930751
Synonyms:
(2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
2-F-ARAA
2-F-ara-A
2-Fluoro Ara-A
2-Fluoro-9-beta-D-arabinofuranosyladenine
2-fluoro ARA-A
21679-14-1
9-beta-D-Arabinofuranosyl-2-fluoroadenine
9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine
9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI)
AC1LCW8I
AC1Q51CF
C10H12FN5O4
CCRIS 3382
CHEMBL1568
CID657237
CPD000058874
D07966
EINECS 244-525-5
F-Ara-A
FAMP
FT-0082766
FaraA
Fludara
Fludara, Fludarabine
 
Fludarabina
Fludarabina [Spanish]
Fludarabine
Fludarabine (INN)
Fludarabine 5'-monophosphate
Fludarabine [INN]
Fludarabine monophosphate
Fludarabine phosphate
Fludarabinum
Fludarabinum [Latin]
Fludura
Fluradosa
Fluradosa (TN)
HSDB 6964
I14-4978
LS-15061
MLS000028687
NSC 118218
NSC 118218H
NSC-118218
S1491_Selleck
SAM002548956
SMR000058874
SQ Fludarabine
UNII-1X9VK9O1SC
UNII-P2K93U8740
ZINC04216238
42
Cytarabineapproved, investigationalPhase 31093147-94-46253
Synonyms:
(beta-D-Arabinofuranosyl)cytosine
(beta-D-arabinofuranosyl)cytosine
1-.beta.-D-arabinofuranosyl-cytosine
1-Arabinofuranosylcytosine
1-beta -D-Arabinofaranosylcytosine
1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone
1-beta -D-Arabinofuranosylcytosine
1-beta-D-Arabinofaranosylcytosine
1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone
1-beta-D-Arabinofuranosyl-Cytosine
1-beta-D-Arabinofuranosylcytosine
1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside
1-beta-D-Arabinosyl-Cytosine
1-beta-D-Arabinosylcytosine
147-94-4
1beta -Arabinofuranasylcytosine
1beta -D-Arabinofuranosylcytosine
1beta -D-Arabinosylcytosine
1beta-Arabinofuranasylcytosine
1beta-D-Arabinofuranosylcytosine
1beta-D-Arabinosylcytosine
2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl- [CAS]
2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl
30399_FLUKA
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech]
4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine
4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech]
4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone
4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one
69-74-9 (hydrochloride)
AC-1075
AC1L1M4F
AC1Q52OJ
AI3-52329
AR3
Alexan
Ara-C
Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine
Ara-Cytidine
AraC
Arabinocytidine
Arabinofuranosyl Cytidine
Arabinofuranosylcytosine
Arabinosyl Cytosine
Arabinosylcytosine
Arabitin
Aracytidine
Aracytin
Aracytine
Arafcyt
BIDD:GT0371
BIDD:PXR0139
BTB15125
Beta-cytosine arabinoside
C02961
C1768_SIGMA
C2035
C9H13N3O5
CCRIS 913
CHEBI:28680
CHEMBL803
CHX 3311
CID6253
CPD000449317
CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9)
Citarabina
Citarabina [INN-Spanish]
Cytarabin
Cytarabina
Cytarabine
Cytarabine (JP15/USP/INN)
 
Cytarabine [USAN:INN:BAN:JAN]
Cytarabine liposome injection
Cytarabinoside
Cytarabinum
Cytarabinum [INN-Latin]
Cytarbel
Cytonal
Cytosar
Cytosar-U
Cytosine 1-beta-D-arabinofuranoside
Cytosine arabinofuranoside
Cytosine arabinose
Cytosine arabinoside
Cytosine arabinoside (VAN)
Cytosine beta-D-arabinofuranoside
Cytosine beta-D-arabinofuranoside hydrochloride
Cytosine beta-D-arabinoside
Cytosine, beta -D-arabinoside
Cytosine, beta-D-arabinoside
Cytosine-1-beta-D-arabinofuranoside
Cytosine-1-beta-D-arabinofuranoside hydrochloride
Cytosine-beta -D-arabinofuranoside
Cytosine-beta -arabinoside
Cytosine-beta-D-arabinofuranoside
Cytosine-beta-arabinoside
Cytosinearabinoside
D00168
DB00987
DepoCyte
Depocyt
Depocyt (TN)
Depocyt (liposomal)
Depocyte
EINECS 205-705-9
Erpalfa
FT-0082880
HMS2051K19
HMS2090A18
HSDB 3049
Intrathecal (injected into the spinal fluid) DepoCyt
Intrathecal cytarabine (also known as ara-C)
Iretin
LS-860
Lopac0_000316
MLS000758310
MLS001066340
MolPort-001-792-509
NCGC00093356-03
NCGC00093356-04
NCGC00093356-05
NCI-C04728
NSC 287459
NSC287459
S1648_Selleck
SAM001247012
SMR000449317
SR-01000075773-3
Spongocytidine
TL8001048
Tarabine
U 19920A
U-19,920
U-19920
UNII-04079A1RDZ
Udicil
ZINC03795098
beta -D-arabinosylcytosine
beta -arabinosylcytosine
beta -cytosine arabinoside
beta-Ara C
beta-Ara c
beta-Arabinosylcytosine
beta-Cytosine arabinoside
beta-D-Arabinosylcytosine
cytarabine
cytarabine liposome injection
cytosine-β-D-arabinofuranoside
43
AsparaginaseapprovedPhase 32229015-68-3
Synonyms:
Asparaginase (E. coli)
 
Elspar
L-asparagine amidohydrolase
Putative L-asparaginase precursor
44
IdarubicinapprovedPhase 321058957-92-942890
Synonyms:
(1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-|A-l-lyxo-hexopyranoside
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione
4-DMD
4-Demethoxydaunomycin
4-Demethoxydaunorubicin
4-Desmethoxydaunorubicin
57852-57-0
57852-57-0 (HYDROCHLORIDE)
58957-92-9
AC1L28SA
AC1Q6JJ4
BRD-K69650333-001-01-1
C26H27NO9
CCRIS 5083
CHEBI:42068
CHEMBL1117
CID42890
D08062
DB01177
DM5
DMDR
EU-0100600
HMS2089D05
I 1656
I06-1097
I1656_SIGMA
IDARUBICIN
 
IMI 30
IMI-30
Idamycin
Idamycin PFS
Idarubicin (INN)
Idarubicin Aglycone
Idarubicin HCl PFS
Idarubicin Hcl
Idarubicin Hcl Pfs
Idarubicin Hydrochloride
Idarubicin [INN:BAN]
Idarubicina
Idarubicina [INN-Spanish]
Idarubicine
Idarubicine [INN-French]
Idarubicinum
Idarubicinum [INN-Latin]
KBioSS_002388
LS-94015
Lopac0_000600
MLS000759470
NCGC00093976-01
NCGC00093976-02
NCGC00093976-03
NCGC00093976-04
NSC-256439
NSC256439
SMR000466355
UNII-ZRP63D75JW
Zavedos
Zavedos (TN)
idarubicin hydrochloride
45
AldesleukinapprovedPhase 339785898-30-2, 110942-02-4
Synonyms:
125-L-serine-2-133-interleukin 2 (human reduced)
 
Interleukin-2 aldesleukin
Interleukin-2(2-133),125-ser
Recombinant interleukin-2 human
46
ThioguanineapprovedPhase 382154-42-72723601
Synonyms:
154-42-7
2 Amino 6 Purinethiol
2-Amino 6MP
2-Amino 6mp
2-Amino-1,7-dihydro-6H-purin-6-thion
2-Amino-1,7-dihydro-6H-purin-6-thion [Czech]
2-Amino-1,7-dihydro-6H-purine-6-thione
2-Amino-6-MP
2-Amino-6-mercaptopurine
2-Amino-6-merkaptopurin
2-Amino-6-merkaptopurin [Czech]
2-Amino-6-purinethiol
2-Amino-9H-purine-6-thiol
2-Aminopurin-6-thiol
2-Aminopurin-6-thiol [Czech]
2-Aminopurine-6(1H)-thione
2-Aminopurine-6-thiol
2-Thioguanine
2-amino-1,9-Dihydropurine-6-thione
2-amino-1H-purine-6(7H)-thione
2-amino-3,7-dihydropurine-6-thione
2-aminopurine-6-thiol
5580-03-0
6 Thioguanine
6-Mercapto-2-aminopurine
6-Mercaptoguanine
6-TG
6-Thioguanine
6-Thioguanine (6-TG)
6-Thioguanine, Thioguanine
A4660_SIGMA
A4882_SIGMA
AC-11125
AC1MC379
AI3-26078
AKOS003389499
BSPBio_001994
BW 5071
C07648
C5H7N5S
CCRIS 8997
CHEBI:136864
CHEMBL727
CID2723601
D013866
D08603
DB00352
DX4
DivK1c_000428
EINECS 205-827-2
FT-0083572
Glaxo Wellcome Brand of Thioguanine
Glaxo Wellcome Brand of Tioguanine
GlaxoSmithKline Brand of Thioguanine
GlaxoSmithKline Brand of Tioguanine
Guanine, thio- (VAN)
HMS1921E09
HMS2092M11
HMS501F10
HSDB 2504
I14-1541
IDI1_000428
KBio1_000428
KBio2_000715
KBio2_002476
KBio2_003283
KBio2_005044
 
KBio2_005851
KBio2_007612
KBio3_001494
KBio3_002954
KBioGR_001452
KBioGR_002476
KBioSS_000715
KBioSS_002483
LS-888
LT00455187
Lanvis
Lanvis (TN)
MLS001333131
MLS001333132
MolPort-000-929-106
MolPort-001-813-204
MolPort-003-984-174
NCGC00094792-01
NCGC00094792-02
NCGC00094792-03
NCI60_041643
NCIOpen2_004153
NINDS_000428
NSC 752
NSC-752
NSC752
S1774_Selleck
SBB067147
SMP2_000326
SMR000857244
SPBio_000849
SPECTRUM1500573
ST50298831
Spectrum2_000695
Spectrum3_000577
Spectrum4_000926
Spectrum5_001455
Spectrum_000235
T0212
TG
THG
Tabloid
ThG
Thioguanin GSK
Thioguanin-GSK
ThioguaninGSK
Thioguanine
Thioguanine Hemihydrate
Thioguanine Monosodium Salt
Thioguanine Tabloid
Thioguanine [USAN:BAN]
Tioguanin
Tioguanina
Tioguanina Wellcome
Tioguanina [INN-Spanish]
Tioguanine
Tioguanine (INN)
Tioguanine GlaxoSmithKline Brand
Tioguaninum
Tioguaninum [INN-Latin]
UNII-FTK8U1GZNX
UNII-WIX31ZPX66
WLN: T56 BNM FYM INJ FUS HZ
Wellcome Brand of Thioguanine
Wellcome U3B
ZINC18085533
cMAP_000061
purine antimetabolite: antimetabolite: inhibits nucleic acid replication
thioguanine
47
MethotrexateapprovedPhase 315181959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall
48
Hydrocortisoneapproved, vet_approvedPhase 364050-23-75754, 657311
Synonyms:
(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
11-Hydrocortisone
11-beta-Hydrocortisone
11-beta-Hydroxycortisone
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b-Hydrocortisone
11b-Hydroxycortisone
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11beta-Hydroxycortisone
11beta-hydrocortisone
11β-hydrocortisone
17-Hydroxycorticosterone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
2v95
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
50-23-7
8056-08-4
80562-38-5
8063-42-1
AC-12902
AC1L1L2B
ACETASOL HC
ACETIC ACID W/ HYDROCORTISONE
AI3-25006
AKOS001582651
Acticort
Acticort (TN)
Aeroseb HC
Aeroseb-HC
Ala-Cort
Ala-Scalp
Alacort
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort
Anucort-HC
Anusol HC
Anusol HC (TN)
Aquacort
Aquanil HC
B48448A1-24BA-47CA-8D9E-43E5BC949386
BPBio1_000544
BRD-K93568044-001-03-1
BSPBio_000494
Balneol-hc
Barseb HC
Basan-Corti
Beta-hc
Bio-0648
C00735
C21H30O5
CCRIS 5854
CHEBI:17650
CHEMBL389621
CID5754
COR-OTICIN
CPD000653523
CaldeCORT Spray
Cetacort
Chronocort
Clear aid
Cleiton
Cobadex
Colocort
Colocort (TN)
Compound F
Compound F (kendall)
Cor-Tar-Quin
Corhydron
Cort-Dome
Cort-Quin
Cortanal
Cortef
Cortef (TN)
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisol, Hydrocortisone
Cortisolonum
Cortisporin
Cortisporin Otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cortril
Cremesone
Cremicort-H
Cutisol
Cyclodextrin-encapsulated hydrocortisone
D00088
DB00741
DB07886
Delacort
Derm-Aid
Dermacort
Dermaspray
Dermil
Dermocortal
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
DuoCort
EINECS 200-020-1
EU-0100594
Ef corlin
Efcorbin
Efcortelan
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
Evacort
Ficortril
Fiocortril
Flexicort
Foille Insetti
Genacort
Genacort (lotion)
Glycort
Gyno-Cortisone
H 4001
H-Cort
H0135_SIGMA
H0396_SIGMA
H0888_SIGMA
H3160_SIGMA
H4001_SIGMA
H6909_SIGMA
HC
HC #1
 
HC #4
HC (HYDROCORTISONE)
HMS1569I16
HMS2090M04
HSDB 3339
HYDROCORTISONE AND ACETIC ACID
HYDROCORTISONE IN ABSORBASE
Heb Cort
Heb-Cort
Hi-cor
Hidalone
Hidro-Colisona
Hidrocortisona
Hidrocortisona [INN-Spanish]
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
Hydro-Adreson
Hydro-Colisona
Hydro-RX
Hydro-colisona
Hydrocort
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone (JP15/USP/INN)
Hydrocortisone Acetate
Hydrocortisone Base
Hydrocortisone Butyrate
Hydrocortisone Sodium Phosphate
Hydrocortisone Valerate
Hydrocortisone [INN:BAN:JAN]
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone free alcohol
Hydrocortisone solution
Hydrocortisone-Water Soluble
Hydrocortisonum
Hydrocortisonum [INN-Latin]
Hydrocortistab
Hydrocortisyl
Hydrocortone
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone (TN)
Hytone lotion
Idrocortisone
Idrocortisone [DCIT]
Incortin-H
Incortin-hydrogen
Kendall'S compound F
Kendall's compound F
Komed HC
Kyypakkaus
LMST02030001
LS-7439
Lacticare HC
Lacticare-HC
Lactisona
Lopac0_000594
Lubricort
MLS000069609
MLS001148103
MLS002207135
MLS002222189
Maintasone
Medicort
Meusicort
Mildison
Milliderm
MolPort-001-794-637
NCGC00022848-06
NCGC00022848-07
NCGC00022848-09
NCGC00022848-12
NCI60_000118
NSC 10483
NSC-10483
NSC10483
Neo-Cort-Dome
Neo-Cortef
Neosporin-H Ear
Nogenic HC
Nutracort
Nystaform-HC
ORLEX HC
Optef
Otalgine
Otic-Neo-Cort-Dome
Otobiotic
Otocort
Otosone-F
Pediotic Suspension
Penecort
Permicort
Polcort H
Preparation H Hydrocortisone Cream
Prepcort
Prestwick0_000447
Prestwick1_000447
Prestwick2_000447
Prestwick3_000447
Prestwick_265
Prevex HC
Proctocort
Proctofoam
Proctozone HC
Protocort
Racet
Rectasol-HC
Rectoid
Reichstein'S substance M
Reichstein's substance M
Remederm HC
S1696_Selleck
SAM002264617
SMP1_000156
SMR000059022
SMR000653523
SPBio_002433
Sanatison
Scalp-Cort
Scalpicin Capilar
Schericur
Scheroson F
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral Hydrocort
Tarcortin
Texacort
Texacort lotion 25
Timocort
Topicort
Transderma H
Traumaide
UNII-WI4X0X7BPJ
UPCMLD-DP133
UPCMLD-DP133:001
Uniderm
Vioform-Hydrocortisone
VoSol HC
Vytone
Zenoxone
[3H]cortisol
component of Lubricort
component of Neo-Cort-Dome
component of Otalgine
hydrocortisone
49
LenograstimapprovedPhase 31202135968-09-1
Synonyms:
G-CSF (CHO cell derived)
Glycosylated recombinant G-CSF
Glycosylated recombinant granulocyte colony stimulating factor
 
Granulocyte colony stimulating factor 3 (CHO cell derived)
Granulocyte colony-stimulating factor lenograstim
Lenograstim (genetical recombination)
Lenograstim rDNA
50
Propranololapproved, investigationalPhase 2, Phase 3216525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
InnoPranXL
 
Innopran XL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol

Interventional clinical trials:

(show all 20)
idNameStatusNCT IDPhase
12NN & CHARM Long-Term Follow-up StudyCompletedNCT00127972Phase 4
2Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-InfectionCompletedNCT00127959Phase 4
3Somnodent vs Herbst in Mild and Moderate OSA PatientsRecruitingNCT02724865Phase 4
4Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de PointesNot yet recruitingNCT02513940Phase 4
5Prevention of Early Mortality by Presumptive Tuberculosis (TB) TreatmentTerminatedNCT01417988Phase 4
6Sequential HIV Therapy in Treatment Resistant HIV-1 Infected PatientsTerminatedNCT00128908Phase 4
7Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002798Phase 3
8The Effects of Propranolol on Fear of Tooth or Molar ExtractionRecruitingNCT02268357Phase 2, Phase 3
9Pilot Study of a National Screening Programme for Bowel Cancer in NorwayEnrolling by invitationNCT01538550Phase 3
10Influence of Progesterone Administration on Drug-Induced QT Interval LengtheningCompletedNCT01929083Phase 2
11Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 InfectionCompletedNCT00128063Phase 1, Phase 2
12The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected PatientsCompletedNCT00400738Phase 2
13Study of Acute Uncomplicated Seasonal Influenza A in Adult SubjectsRecruitingNCT02342249Phase 2
14Vagus Nerve Stimulation for Treating Adults With Severe FibromyalgiaCompletedNCT00294281Phase 1
15RCT: Effectiveness of a Microscope During Dental Root Apical SurgeryUnknown statusNCT01759069
16Combined Nutrient Intake and Muscle Protein SynthesisCompletedNCT01239277
17MRI Study After Arterial Switch Operation in Patients With Transposition of the Great ArteriesCompletedNCT01916499
18The Long QT Syndrome in PregnancyCompletedNCT00488254
19IMproved PREdiction of Severe Sepsis in the Emergency DepartmentCompletedNCT01392508
20Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT01793168

Search NIH Clinical Center for Cornelia De Lange Syndrome 1


Cochrane evidence based reviews: de lange syndrome

Genetic Tests for Cornelia De Lange Syndrome 1

About this section

Genetic tests related to Cornelia De Lange Syndrome 1:

id Genetic test Affiliating Genes
1 De Lange Syndrome27
2 Cornelia De Lange Syndrome 127
3 Cornelia De Lange Syndrome24 SMC3

Anatomical Context for Cornelia De Lange Syndrome 1

About this section

MalaCards organs/tissues related to Cornelia De Lange Syndrome 1:

36
Bone, Kidney, Uterus, Colon, Cerebellum, Eye, Bone marrow

Publications for Cornelia De Lange Syndrome 1

About this section

Articles related to Cornelia De Lange Syndrome 1:

idTitleAuthorsYear
1
Self-injurious behaviour in Cornelia de Lange syndrome: 1. Prevalence and phenomenology. (19522788)
2009

Variations for Cornelia De Lange Syndrome 1

About this section

UniProtKB/Swiss-Prot genetic disease variations for Cornelia De Lange Syndrome 1:

70 (show all 38)
id Symbol AA change Variation ID SNP ID
1NIPBLp.Cys1311ArgVAR_019519
2NIPBLp.Leu1348ArgVAR_019520
3NIPBLp.Tyr2430CysVAR_019521rs121918265
4NIPBLp.Ala1246GlyVAR_021598rs121918268
5NIPBLp.Leu1312ProVAR_021599
6NIPBLp.Arg1789LeuVAR_021600
7NIPBLp.Asp1803ValVAR_021601
8NIPBLp.Arg1856ThrVAR_021602
9NIPBLp.Arg2298CysVAR_021603rs80358376
10NIPBLp.Arg2298HisVAR_021604rs587784024
11NIPBLp.Gly2312ArgVAR_021605
12NIPBLp.Gly2381AlaVAR_021606
13NIPBLp.Ala2390ThrVAR_021607rs587784036
14NIPBLp.Tyr2440HisVAR_021608
15NIPBLp.Gly2081AlaVAR_064545
16NIPBLp.Ser2090IleVAR_064546
17NIPBLp.Leu2150ProVAR_064547
18NIPBLp.Gly15ArgVAR_072996
19NIPBLp.Pro29GlnVAR_072997
20NIPBLp.Asn70IleVAR_072998
21NIPBLp.Ser111ThrVAR_073000
22NIPBLp.Ala179SerVAR_073001
23NIPBLp.Ala179ThrVAR_073002rs142923613
24NIPBLp.Pro192LeuVAR_073003
25NIPBLp.Asp246GlyVAR_073004rs587784042
26NIPBLp.Leu254ValVAR_073005
27NIPBLp.Pro351ThrVAR_073006
28NIPBLp.Lys357AsnVAR_073007
29NIPBLp.Arg868GlnVAR_073008rs149629686
30NIPBLp.Glu1207LysVAR_073009
31NIPBLp.His1343ProVAR_073010
32NIPBLp.Val1441LeuVAR_073011rs727503769
33NIPBLp.Val1625PheVAR_073012
34NIPBLp.Ile1637LeuVAR_073013
35NIPBLp.Asn1722HisVAR_073014
36NIPBLp.Cys2091PheVAR_073015
37NIPBLp.Gly2312ValVAR_073017rs587784025
38NIPBLp.Asp2433AsnVAR_073018

Clinvar genetic disease variations for Cornelia De Lange Syndrome 1:

5 (show all 241)
id Gene Variation Type Significance SNP ID Assembly Location
1NIPBLNM_015384.4(NIPBL): c.1003delG (p.Glu335Lysfs)deletionPathogenicrs587783877GRCh37Chr 5, 36976012: 36976012
2NIPBLNM_015384.4(NIPBL): c.1033_1036delTATG (p.Tyr345Ilefs)deletionPathogenicrs587783878GRCh37Chr 5, 36976042: 36976045
3NIPBLNM_133433.3(NIPBL): c.1057A> T (p.Lys353Ter)SNVPathogenicrs587783879GRCh37Chr 5, 36976066: 36976066
4NIPBLNM_015384.4(NIPBL): c.1086_1087delTT (p.Arg364Cysfs)deletionPathogenicrs587783880GRCh38Chr 5, 36975993: 36975994
5NIPBLNM_133433.3(NIPBL): c.1183C> T (p.Gln395Ter)SNVPathogenicrs587783882GRCh37Chr 5, 36976192: 36976192
6NIPBLNM_133433.3(NIPBL): c.1297C> T (p.Gln433Ter)SNVPathogenicrs587783883GRCh37Chr 5, 36976306: 36976306
7NIPBLNM_133433.3(NIPBL): c.1372C> T (p.Gln458Ter)SNVPathogenicrs587783884GRCh37Chr 5, 36976381: 36976381
8NIPBLNM_015384.4(NIPBL): c.1447_1448delGA (p.Glu483Ilefs)deletionPathogenicrs587783885GRCh37Chr 5, 36976456: 36976457
9NIPBLNM_133433.3(NIPBL): c.145G> T (p.Glu49Ter)SNVPathogenicrs587783886GRCh37Chr 5, 36955654: 36955654
10NIPBLNM_133433.3(NIPBL): c.1477A> G (p.Lys493Glu)SNVLikely pathogenicrs587783887GRCh37Chr 5, 36976486: 36976486
11NIPBLNM_015384.4(NIPBL): c.1514_1517delGAAA (p.Arg505Asnfs)deletionPathogenicrs587783888GRCh37Chr 5, 36984796: 36984799
12NIPBLNM_133433.3(NIPBL): c.1576C> T (p.Gln526Ter)SNVPathogenicrs587783889GRCh37Chr 5, 36984858: 36984858
13NIPBLNM_015384.4(NIPBL): c.1753delA (p.Ile585Leufs)deletionPathogenicrs587783891GRCh37Chr 5, 36985035: 36985035
14NIPBLNM_133433.3(NIPBL): c.1885C> T (p.Arg629Ter)SNVPathogenicrs587783892GRCh37Chr 5, 36985167: 36985167
15NIPBLNM_015384.4(NIPBL): c.201_212delTAGCCTCAACCA (p.His67_Asn70del)deletionLikely pathogenicrs587783893GRCh37Chr 5, 36955710: 36955721
16NIPBLNM_015384.4(NIPBL): c.2046delA (p.Lys682Asnfs)deletionPathogenicrs587783894GRCh37Chr 5, 36985328: 36985328
17NIPBLNM_133433.3(NIPBL): c.206T> C (p.Leu69Pro)SNVLikely pathogenicrs587783895GRCh37Chr 5, 36955715: 36955715
18NIPBLNM_133433.3(NIPBL): c.2093C> G (p.Ser698Ter)SNVPathogenicrs587783896GRCh37Chr 5, 36985375: 36985375
19NIPBLNM_015384.4(NIPBL): c.2107_2108delCC (p.Pro703Lysfs)deletionPathogenicrs587783897GRCh37Chr 5, 36985389: 36985390
20NIPBLNM_015384.4(NIPBL): c.2108delC (p.Pro703Glnfs)deletionPathogenicrs587783898GRCh37Chr 5, 36985390: 36985390
21NIPBLNM_133433.3(NIPBL): c.2260C> T (p.Arg754Ter)SNVPathogenicrs587783899GRCh37Chr 5, 36985542: 36985542
22NIPBLNM_133433.3(NIPBL): c.2389C> T (p.Arg797Ter)SNVPathogenicrs587783901GRCh37Chr 5, 36985671: 36985671
23NIPBLNM_133433.3(NIPBL): c.2422C> T (p.Arg808Ter)SNVPathogenicrs587783902GRCh37Chr 5, 36985704: 36985704
24NIPBLNM_133433.3(NIPBL): c.2489C> G (p.Ser830Ter)SNVPathogenicrs587783905GRCh37Chr 5, 36985771: 36985771
25NIPBLNM_133433.3(NIPBL): c.2494C> T (p.Arg832Ter)SNVPathogenicrs587783906GRCh37Chr 5, 36985776: 36985776
26NIPBLNM_133433.3(NIPBL): c.2500C> T (p.Arg834Ter)SNVPathogenicrs587783907GRCh37Chr 5, 36985782: 36985782
27NIPBLNM_015384.4(NIPBL): c.2711delG (p.Arg904Asnfs)deletionPathogenicrs587783909GRCh37Chr 5, 36985993: 36985993
28NIPBLNM_015384.4(NIPBL): c.2773_2774delAA (p.Lys925Glufs)deletionPathogenicrs587783910GRCh37Chr 5, 36986055: 36986056
29NIPBLNM_133433.3(NIPBL): c.2832T> A (p.Tyr944Ter)SNVPathogenicrs587783911GRCh37Chr 5, 36986114: 36986114
30NIPBLNM_015384.4(NIPBL): c.2903delA (p.Asn968Metfs)deletionPathogenicrs587783912GRCh37Chr 5, 36986185: 36986185
31NIPBLNM_133433.3(NIPBL): c.3060_3063delAGAG (p.Glu1021Thrfs)deletionPathogenicrs587783914GRCh37Chr 5, 36986342: 36986345
32NIPBLNM_015384.4(NIPBL): c.310_317delCCTAATGT (p.Pro104Phefs)deletionPathogenicrs587783917GRCh37Chr 5, 36958285: 36958292
33NIPBLNM_133433.3(NIPBL): c.3122-2A> GSNVLikely pathogenicrs587783918GRCh37Chr 5, 36995722: 36995722
34NIPBLNM_133433.3(NIPBL): c.3304+5G> ASNVLikely pathogenicrs80358356GRCh37Chr 5, 36995911: 36995911
35NIPBLNM_133433.3(NIPBL): c.3305-1G> TSNVPathogenicrs80358375GRCh37Chr 5, 37000474: 37000474
36NIPBLNM_133433.3(NIPBL): c.3322A> T (p.Lys1108Ter)SNVPathogenicrs587783919GRCh37Chr 5, 37000492: 37000492
37NIPBLNM_133433.3(NIPBL): c.3440G> A (p.Arg1147Gln)SNVLikely pathogenicrs587783921GRCh37Chr 5, 37000610: 37000610
38NIPBLNM_133433.3(NIPBL): c.345A> G (p.Arg115=)SNVLikely pathogenicrs587783922GRCh37Chr 5, 36958320: 36958320
39NIPBLNM_015384.4(NIPBL): c.3461_3462delCT (p.Ser1154Terfs)deletionPathogenicrs587783923GRCh37Chr 5, 37000631: 37000632
40NIPBLNM_015384.4(NIPBL): c.3526_3530delGAAAA (p.Glu1176Thrfs)deletionPathogenicrs587783925GRCh37Chr 5, 37000942: 37000946
41NIPBLNM_133433.3(NIPBL): c.3575-3C> GSNVPathogenicrs587783926GRCh37Chr 5, 37001088: 37001088
42NIPBLNM_133433.3(NIPBL): c.358+1G> TSNVPathogenicrs587783927GRCh37Chr 5, 36958334: 36958334
43NIPBLNM_133433.3(NIPBL): c.358+5G> CSNVLikely pathogenicrs587783928GRCh37Chr 5, 36958338: 36958338
44NIPBLNM_015384.4(NIPBL): c.3788_3789delTG (p.Val1263Glufs)deletionPathogenicrs587783930GRCh37Chr 5, 37003382: 37003383
45NIPBLNM_015384.4(NIPBL): c.3804_3818delCTTGGAGAAGAATAT (p.Leu1269_Ile1273del)deletionLikely pathogenicrs587783931GRCh37Chr 5, 37003398: 37003412
46NIPBLNM_133433.3(NIPBL): c.3818T> G (p.Ile1273Ser)SNVLikely pathogenicrs587783932GRCh37Chr 5, 37003412: 37003412
47NIPBLNM_133433.3(NIPBL): c.3855+1G> TSNVPathogenicrs587783933GRCh37Chr 5, 37003450: 37003450
48NIPBLNM_133433.3(NIPBL): c.3855+5G> ASNVLikely pathogenicrs80358378GRCh37Chr 5, 37003454: 37003454
49NIPBLNM_015384.4(NIPBL): c.3866_3869delCTGA (p.Thr1289Lysfs)deletionPathogenicrs587783934GRCh37Chr 5, 37006469: 37006472
50NIPBLNM_133433.3(NIPBL): c.3874G> T (p.Glu1292Ter)SNVPathogenicrs587783936GRCh37Chr 5, 37006477: 37006477
51NIPBLNM_133433.3(NIPBL): c.3G> T (p.Met1Ile)SNVPathogenicrs587783937GRCh37Chr 5, 36953801: 36953801
52NIPBLNM_133433.3(NIPBL): c.4017C> A (p.Tyr1339Ter)SNVPathogenicrs587783938GRCh37Chr 5, 37006620: 37006620
53NIPBLNM_133433.3(NIPBL): c.4088-2A> TSNVPathogenicrs587783939GRCh37Chr 5, 37007423: 37007423
54NIPBLNM_015384.4(NIPBL): c.4098_4101delAAGT (p.Leu1366Phefs)deletionPathogenicrs587783940GRCh37Chr 5, 37007435: 37007438
55NIPBLNM_015384.4(NIPBL): c.4143_4144delAG (p.Arg1381Serfs)deletionPathogenicrs587783941GRCh37Chr 5, 37007480: 37007481
56NIPBLNM_133433.3(NIPBL): c.4240-1G> CSNVPathogenicrs587783942GRCh37Chr 5, 37008109: 37008109
57NIPBLNM_015384.4(NIPBL): c.4275_4287delAAATGTCAGTGAA (p.Glu1425Aspfs)deletionPathogenicrs587783944GRCh37Chr 5, 37008145: 37008157
58NIPBLNM_133433.3(NIPBL): c.4320+1G> ASNVPathogenicrs587783945GRCh37Chr 5, 37008191: 37008191
59NIPBLNM_133433.3(NIPBL): c.4421G> C (p.Arg1474Thr)SNVLikely pathogenicrs587783947GRCh37Chr 5, 37008825: 37008825
60NIPBLNM_133433.3(NIPBL): c.4439T> G (p.Met1480Arg)SNVLikely pathogenicrs587783948GRCh37Chr 5, 37010206: 37010206
61NIPBLNM_133433.3(NIPBL): c.4543G> T (p.Glu1515Ter)SNVPathogenicrs587783950GRCh37Chr 5, 37010310: 37010310
62NIPBLNM_015384.4(NIPBL): c.456delC (p.Ser153Alafs)deletionPathogenicrs587783951GRCh37Chr 5, 36961683: 36961683
63NIPBLNM_133433.3(NIPBL): c.4593T> G (p.Tyr1531Ter)SNVPathogenicrs587783952GRCh37Chr 5, 37014817: 37014817
64NIPBLNM_015384.4(NIPBL): c.4636delC (p.Lys1548Asnfs)deletionPathogenicrs587783953GRCh37Chr 5, 37014860: 37014860
65NIPBLNM_133433.3(NIPBL): c.4643+1G> CSNVPathogenicrs587783954GRCh37Chr 5, 37014868: 37014868
66NIPBLNM_015384.4(NIPBL): c.4663delG (p.Glu1555Lysfs)deletionPathogenicrs587783955GRCh37Chr 5, 37016159: 37016159
67NIPBLNM_015384.4(NIPBL): c.4684_4687delTTTG (p.Phe1562Lysfs)deletionPathogenicrs587783957GRCh37Chr 5, 37016180: 37016183
68NIPBLNM_133433.3(NIPBL): c.4712C> A (p.Ser1571Ter)SNVPathogenicrs77632238GRCh37Chr 5, 37016208: 37016208
69NIPBLNM_015384.4(NIPBL): c.4818_4819delAG (p.Arg1606Serfs)deletionPathogenicrs587783959GRCh37Chr 5, 37017162: 37017163
70NIPBLNM_015384.4(NIPBL): c.5033_5039delCCCAGTG (p.Ala1678Glyfs)deletionPathogenicrs587783960GRCh37Chr 5, 37020583: 37020589
71NIPBLNM_015384.4(NIPBL): c.5174delA (p.Lys1725Serfs)deletionPathogenicrs587783961GRCh37Chr 5, 37020724: 37020724
72NIPBLNM_133433.3(NIPBL): c.5327A> T (p.Gln1776Leu)SNVLikely pathogenicrs587783966GRCh37Chr 5, 37020978: 37020978
73NIPBLNM_133433.3(NIPBL): c.5328+1G> ASNVPathogenicrs587783967GRCh37Chr 5, 37020980: 37020980
74NIPBLNM_133433.3(NIPBL): c.5329-1G> CSNVPathogenicrs587783969GRCh37Chr 5, 37022152: 37022152
75NIPBLNM_133433.3(NIPBL): c.5335C> T (p.Arg1779Ter)SNVPathogenicrs587783971GRCh37Chr 5, 37022159: 37022159
76NIPBLNM_133433.3(NIPBL): c.5365C> T (p.Arg1789Ter)SNVPathogenicrs587783972GRCh37Chr 5, 37022189: 37022189
77NIPBLNM_015384.4(NIPBL): c.5389_5392delTCTG (p.Ser1797Argfs)deletionPathogenicrs587783973GRCh37Chr 5, 37022213: 37022216
78NIPBLNM_133433.3(NIPBL): c.5428-2A> GSNVPathogenicrs587783974GRCh37Chr 5, 37022344: 37022344
79NIPBLNM_133433.3(NIPBL): c.5455C> T (p.Arg1819Ter)SNVPathogenicrs587783975GRCh37Chr 5, 37022373: 37022373
80NIPBLNM_133433.3(NIPBL): c.5465A> G (p.Asp1822Gly)SNVLikely pathogenicrs587783977GRCh37Chr 5, 37022383: 37022383
81NIPBLNM_133433.3(NIPBL): c.5482C> T (p.Arg1828Ter)SNVPathogenicrs62654864GRCh37Chr 5, 37022400: 37022400
82NIPBLNM_133433.3(NIPBL): c.5483G> A (p.Arg1828Gln)SNVPathogenicrs587783978GRCh37Chr 5, 37022401: 37022401
83NIPBLNM_133433.3(NIPBL): c.5709+1G> ASNVPathogenicrs587783979GRCh37Chr 5, 37024822: 37024822
84NIPBLNM_133433.3(NIPBL): c.5709+2T> GSNVPathogenicrs587783980GRCh37Chr 5, 37024823: 37024823
85NIPBLNM_133433.3(NIPBL): c.5732A> C (p.Gln1911Pro)SNVLikely pathogenicrs587783982GRCh37Chr 5, 37026353: 37026353
86NIPBLNM_133433.3(NIPBL): c.5808+1G> ASNVPathogenicrs587783984GRCh37Chr 5, 37026430: 37026430
87NIPBLNM_133433.3(NIPBL): c.5862+1G> ASNVPathogenicrs587783985GRCh37Chr 5, 37027515: 37027515
88NIPBLNM_133433.3(NIPBL): c.5923G> T (p.Val1975Phe)SNVLikely pathogenicrs587783986GRCh37Chr 5, 37036541: 37036541
89NIPBLNM_015384.4(NIPBL): c.5924_5926delTTG (p.Val1975del)deletionLikely pathogenicrs587783987GRCh37Chr 5, 37036542: 37036544
90NIPBLNM_133433.3(NIPBL): c.598C> T (p.Gln200Ter)SNVPathogenicrs587783988GRCh37Chr 5, 36962364: 36962364
91NIPBLNM_133433.3(NIPBL): c.610+1G> ASNVPathogenicrs587783993GRCh37Chr 5, 36962377: 36962377
92NIPBLNM_133433.3(NIPBL): c.6108+1G> TSNVPathogenicrs587783994GRCh37Chr 5, 37038841: 37038841
93NIPBLNM_133433.3(NIPBL): c.6158T> C (p.Leu2053Pro)SNVLikely pathogenicrs587783997GRCh37Chr 5, 37044498: 37044498
94NIPBLNM_133433.3(NIPBL): c.6170T> C (p.Leu2057Pro)SNVLikely pathogenicrs587783998GRCh37Chr 5, 37044510: 37044510
95NIPBLNM_133433.3(NIPBL): c.6242G> T (p.Gly2081Val)SNVLikely pathogenicrs587784000GRCh37Chr 5, 37044582: 37044582
96NIPBLNM_133433.3(NIPBL): c.6250G> T (p.Val2084Leu)SNVLikely pathogenicrs587784002GRCh37Chr 5, 37044738: 37044738
97NIPBLNM_133433.3(NIPBL): c.6266T> G (p.Val2089Gly)SNVLikely pathogenicrs587784003GRCh37Chr 5, 37044754: 37044754
98NIPBLNM_133433.3(NIPBL): c.6316G> C (p.Val2106Leu)SNVLikely pathogenicrs587784004GRCh37Chr 5, 37044804: 37044804
99NIPBLNM_015384.4(NIPBL): c.6317_6320delTGTG (p.Val2106Glyfs)deletionPathogenicrs587784005GRCh37Chr 5, 37044805: 37044808
100NIPBLNM_133433.3(NIPBL): c.6343G> A (p.Gly2115Ser)SNVLikely pathogenicrs587784007GRCh37Chr 5, 37044831: 37044831
101NIPBLNM_015384.4(NIPBL): c.6362_6364delAAA (p.Lys2121del)deletionLikely pathogenicrs587784008GRCh37Chr 5, 37045563: 37045565
102NIPBLNM_133433.3(NIPBL): c.64+1G> ASNVPathogenicrs587784009GRCh37Chr 5, 36953863: 36953863
103NIPBLNM_133433.3(NIPBL): c.64+3A> CSNVPathogenicrs587784010GRCh37Chr 5, 36953865: 36953865
104NIPBLNM_133433.3(NIPBL): c.64+5G> ASNVLikely pathogenicrs587784011GRCh37Chr 5, 36953867: 36953867
105NIPBLNM_133433.3(NIPBL): c.6478G> T (p.Asp2160Tyr)SNVLikely pathogenicrs147054690GRCh37Chr 5, 37045679: 37045679
106NIPBLNM_133433.3(NIPBL): c.65-5A> GSNVLikely pathogenicrs587784012GRCh37Chr 5, 36955569: 36955569
107NIPBLNM_133433.3(NIPBL): c.6565C> T (p.Gln2189Ter)SNVPathogenicrs587784013GRCh37Chr 5, 37046277: 37046277
108NIPBLNM_133433.3(NIPBL): c.6571A> T (p.Lys2191Ter)SNVPathogenicrs587784015GRCh37Chr 5, 37046283: 37046283
109NIPBLNM_133433.3(NIPBL): c.6590-2A> CSNVPathogenicrs587784016GRCh37Chr 5, 37048602: 37048602
110NIPBLNM_133433.3(NIPBL): c.6590G> A (p.Gly2197Glu)SNVPathogenicrs587784017GRCh37Chr 5, 37048604: 37048604
111NIPBLNM_015384.4(NIPBL): c.6632_6634delAAG (p.Glu2211del)deletionLikely pathogenicrs587784019GRCh37Chr 5, 37048646: 37048648
112NIPBLNM_015384.4(NIPBL): c.6648_6649delTA (p.Tyr2216Terfs)deletionPathogenicrs587784021GRCh37Chr 5, 37048662: 37048663
113NIPBLNM_015384.4(NIPBL): c.6653_6655delATA (p.Asn2218del)deletionPathogenicrs587784022GRCh37Chr 5, 37048667: 37048669
114NIPBLNM_133433.3(NIPBL): c.6707A> T (p.Asn2236Ile)SNVPathogenicrs587784023GRCh37Chr 5, 37048721: 37048721
115NIPBLNM_133433.3(NIPBL): c.6892C> T (p.Arg2298Cys)SNVPathogenicrs80358376GRCh37Chr 5, 37049341: 37049341
116NIPBLNM_133433.3(NIPBL): c.6893G> A (p.Arg2298His)SNVPathogenicrs587784024GRCh37Chr 5, 37049342: 37049342
117NIPBLNM_133433.3(NIPBL): c.6935G> T (p.Gly2312Val)SNVLikely pathogenicrs587784025GRCh37Chr 5, 37049384: 37049384
118NIPBLNM_133433.3(NIPBL): c.6952C> T (p.Gln2318Ter)SNVPathogenicrs587784026GRCh37Chr 5, 37049401: 37049401
119NIPBLNM_133433.3(NIPBL): c.6954+1G> ASNVPathogenicrs587784027GRCh37Chr 5, 37049404: 37049404
120NIPBLNM_015384.4(NIPBL): c.7011_7012delGG (p.Lys2337Asnfs)deletionPathogenicrs587784029GRCh37Chr 5, 37051937: 37051938
121NIPBLNM_133433.3(NIPBL): c.7012G> C (p.Ala2338Pro)SNVLikely pathogenic, Pathogenicrs587784030GRCh37Chr 5, 37051938: 37051938
122NIPBLNM_133433.3(NIPBL): c.7062+2T> CSNVPathogenicrs587784032GRCh37Chr 5, 37051990: 37051990
123NIPBLNM_133433.3(NIPBL): c.7102C> T (p.Gln2368Ter)SNVPathogenicrs587784033GRCh37Chr 5, 37052507: 37052507
124NIPBLNM_015384.4(NIPBL): c.7106delA (p.Gln2369Argfs)deletionPathogenicrs587784034GRCh37Chr 5, 37052511: 37052511
125NIPBLNM_133433.3(NIPBL): c.7141G> A (p.Gly2381Ser)SNVLikely pathogenicrs587784035GRCh37Chr 5, 37052546: 37052546
126NIPBLNM_133433.3(NIPBL): c.7168G> A (p.Ala2390Thr)SNVPathogenicrs587784036GRCh37Chr 5, 37052573: 37052573
127NIPBLNM_015384.4(NIPBL): c.7198delC (p.Arg2400Valfs)deletionPathogenicrs587784037GRCh37Chr 5, 37052603: 37052603
128NIPBLNM_133433.3(NIPBL): c.7264-6T> GSNVPathogenicrs587784038GRCh37Chr 5, 37057282: 37057282
129NIPBLNM_133433.3(NIPBL): c.7306G> A (p.Ala2436Thr)SNVLikely pathogenicrs587784039GRCh37Chr 5, 37057330: 37057330
130NIPBLNM_015384.4(NIPBL): c.7336_7338delCCG (p.Pro2446del)deletionLikely pathogenicrs587784040GRCh37Chr 5, 37057360: 37057362
131NIPBLNM_133433.3(NIPBL): c.737A> G (p.Asp246Gly)SNVPathogenicrs587784042GRCh37Chr 5, 36971104: 36971104
132NIPBLNM_015384.4(NIPBL): c.7439_7440delGA (p.Arg2480Lysfs)deletionPathogenicrs587784043GRCh37Chr 5, 37059021: 37059022
133NIPBLNM_015384.4(NIPBL): c.7701_7725del25 (p.Ser2568Metfs)deletionPathogenicrs587784047GRCh37Chr 5, 37060961: 37060985
134NIPBLNM_133433.3(NIPBL): c.771+1G> ASNVPathogenicrs587784048GRCh37Chr 5, 36971139: 36971139
135NIPBLNM_133433.3(NIPBL): c.772-1G> ASNVPathogenicrs587784049GRCh37Chr 5, 36972046: 36972046
136NIPBLNM_133433.3(NIPBL): c.7849C> T (p.Gln2617Ter)SNVPathogenicrs587784050GRCh37Chr 5, 37061109: 37061109
137NIPBLNM_133433.3(NIPBL): c.8165_8183del19 (p.Pro2722Argfs)deletionPathogenicrs587784052GRCh37Chr 5, 37064744: 37064762
138NIPBLNM_133433.3(NIPBL): c.8173G> C (p.Ala2725Pro)SNVLikely pathogenicrs587784053GRCh37Chr 5, 37064752: 37064752
139NIPBLNM_133433.3(NIPBL): c.8277_8283delGGTGCCT (p.Val2760Glyfs)deletionPathogenicrs587784055GRCh37Chr 5, 37064856: 37064862
140NIPBLNM_133433.3(NIPBL): c.8300_8301delAA (p.Lys2767Argfs)deletionPathogenicrs587784056GRCh37Chr 5, 37064879: 37064880
141NIPBLNM_133433.3(NIPBL): c.869-1G> ASNVPathogenicrs587784059GRCh37Chr 5, 36975877: 36975877
142NIPBLNM_015384.4(NIPBL): c.86delC (p.Pro29Hisfs)deletionPathogenicrs587784060GRCh37Chr 5, 36955595: 36955595
143NIPBLNM_133433.3(NIPBL): c.892C> T (p.Gln298Ter)SNVPathogenicrs587784062GRCh37Chr 5, 36975901: 36975901
144NIPBLNM_015384.4(NIPBL): c.892delC (p.Gln298Asnfs)deletionPathogenicrs587784063GRCh37Chr 5, 36975901: 36975901
145NIPBLNM_133433.3(NIPBL): c.922C> T (p.Arg308Ter)SNVPathogenicrs587784065GRCh37Chr 5, 36975931: 36975931
146NIPBLNM_015384.4(NIPBL): c.6701T> G (p.Leu2234Ter)SNVPathogenicrs727504047GRCh37Chr 5, 37048715: 37048715
147NIPBLNM_015384.4(NIPBL): c.5212dupT (p.Ser1739Terfs)duplicationPathogenicrs730880331GRCh37Chr 5, 37020762: 37020762
148NIPBLNM_015384.4(NIPBL): c.2147_2148delAA (p.Lys717Glufs)deletionPathogenicrs727503766GRCh37Chr 5, 36985429: 36985430
149NIPBLNM_015384.4(NIPBL): c.1801delA (p.Lys603Serfs)deletionPathogenicrs727503767GRCh38Chr 5, 36984981: 36984981
150NIPBLNM_015384.4(NIPBL): c.65-3T> GSNVPathogenicrs727503768GRCh38Chr 5, 36955469: 36955469
151NIPBLNM_015384.4(NIPBL): c.4321G> T (p.Val1441Leu)SNVPathogenicrs727503769GRCh37Chr 5, 37008725: 37008725
152NIPBLNM_015384.4(NIPBL): c.914C> A (p.Ser305Ter)SNVPathogenicrs727503770GRCh38Chr 5, 36975821: 36975821
153NIPBLNM_015384.4(NIPBL): c.7900_7937del38 (p.Glu2635Glnfs)deletionPathogenicrs727503771GRCh37Chr 5, 37063931: 37063968
154NIPBLNM_015384.4(NIPBL): c.7637T> C (p.Leu2546Pro)SNVPathogenicrs727503772GRCh38Chr 5, 37059117: 37059117
155KMT2ANM_005933.3(KMT2A): c.2233C> T (p.Arg745Ter)SNVPathogenicrs727503777GRCh38Chr 11, 118473392: 118473392
156TAF6NM_005641.3(TAF6): c.136C> T (p.Arg46Cys)SNVPathogenicrs727503778GRCh38Chr 7, 100114074: 100114074
157NIPBLNM_015384.4(NIPBL): c.5808+2T> GSNVPathogenicrs794727556GRCh37Chr 5, 37026431: 37026431
158NIPBLNM_015384.4(NIPBL): c.6108+1G> CSNVPathogenicrs587783994GRCh37Chr 5, 37038841: 37038841
159NIPBLNM_015384.4(NIPBL): c.1146dupT (p.Ser383Terfs)duplicationPathogenicrs797045745GRCh38Chr 5, 36976053: 36976053
160NIPBLNM_015384.4(NIPBL): c.1448_1449delAAinsCTCCCTT (p.Glu483Alafs)indelPathogenicrs797045746GRCh38Chr 5, 36976355: 36976356
161NIPBLNM_133433.3(NIPBL): c.1496-8A> GSNVLikely pathogenicrs797045747GRCh38Chr 5, 36984668: 36984668
162NIPBLNM_015384.4(NIPBL): c.1992dupC (p.Glu665Argfs)duplicationPathogenicrs797045748GRCh37Chr 5, 36985274: 36985274
163NIPBLNM_015384.4(NIPBL): c.212_213dupAG (p.Val72Argfs)duplicationPathogenicrs797045749GRCh38Chr 5, 36955619: 36955620
164NIPBLNM_015384.4(NIPBL): c.2394_2397dupTGAA (p.Ala800Terfs)duplicationPathogenicrs797045750GRCh37Chr 5, 36985676: 36985679
165NIPBLNM_015384.4(NIPBL): c.2464delC (p.Gln822Lysfs)deletionPathogenicrs797045751GRCh38Chr 5, 36985644: 36985644
166NIPBLNM_133433.3(NIPBL): c.2521C> T (p.Arg841Ter)SNVPathogenicrs797045752GRCh38Chr 5, 36985701: 36985701
167NIPBLNM_133433.3(NIPBL): c.286_287insG (p.Leu96Cysfs)insertionPathogenicrs797045753GRCh38Chr 5, 36958159: 36958160
168NIPBLNM_015384.4(NIPBL): c.2965dupA (p.Ile989Asnfs)duplicationPathogenicrs797045754GRCh38Chr 5, 36986145: 36986145
169NIPBLNM_015384.4(NIPBL): c.314dupA (p.Asn105Lysfs)duplicationPathogenicrs797045755GRCh38Chr 5, 36958187: 36958187
170NIPBLNM_015384.4(NIPBL): c.3264delC (p.Ser1089Valfs)deletionPathogenicrs797045756GRCh38Chr 5, 36995764: 36995764
171NIPBLNM_133433.3(NIPBL): c.3856-7_3856-5deldeletionLikely pathogenicrs797045757GRCh38Chr 5, 37006350: 37006352
172NIPBLNM_133433.3(NIPBL): c.4320+2dupduplicationLikely pathogenicrs797045758GRCh38Chr 5, 37008090: 37008090
173NIPBLNM_133433.3(NIPBL): c.4495C> T (p.Gln1499Ter)SNVPathogenicrs797045760GRCh38Chr 5, 37010160: 37010160
174NIPBLNM_133433.3(NIPBL): c.4529dupA (p.Asp1510Glufs)duplicationPathogenicrs797045761GRCh38Chr 5, 37010194: 37010194
175NIPBLNM_015384.4(NIPBL): c.4532_4533delCT (p.Ser1511Terfs)deletionPathogenicrs797045762GRCh37Chr 5, 37010299: 37010300
176NIPBLNM_133433.3(NIPBL): c.458+1_458+2dupduplicationPathogenicrs797045763GRCh38Chr 5, 36961584: 36961585
177NIPBLNM_133433.3(NIPBL): c.4580_4581insCCTGTCAACTAACATGT (p.Thr1528Leufs)insertionPathogenicrs797045764GRCh38Chr 5, 37014702: 37014703
178NIPBLNM_015384.4(NIPBL): c.4893dupA (p.Gly1632Argfs)duplicationPathogenicrs797045766GRCh38Chr 5, 37017135: 37017135
179NIPBLNM_133433.3(NIPBL): c.4965_4972delGCTTGATT (p.Asp1657Glyfs)deletionPathogenicrs797045767GRCh38Chr 5, 37019355: 37019362
180NIPBLNM_015384.4(NIPBL): c.4988_4991dupCTGA (p.Glu1664Aspfs)duplicationPathogenicrs797045768GRCh38Chr 5, 37019378: 37019381
181NIPBLNM_133433.3(NIPBL): c.5044C> T (p.Arg1682Ter)SNVPathogenicrs797045769GRCh38Chr 5, 37020492: 37020492
182NIPBLNM_133433.3(NIPBL): c.5046_5047insTG (p.Asp1683Trpfs)insertionPathogenicrs797045770GRCh37Chr 5, 37020596: 37020597
183NIPBLNM_133433.3(NIPBL): c.5580dupT (p.Gly1861Trpfs)duplicationPathogenicrs797045771GRCh38Chr 5, 37024590: 37024590
184NIPBLNM_015384.4(NIPBL): c.5679dupT (p.Arg1894Serfs)duplicationPathogenicrs797045772GRCh38Chr 5, 37024689: 37024689
185NIPBLNM_015384.4(NIPBL): c.5739_5740delCT (p.Trp1914Valfs)deletionPathogenicrs797045773GRCh37Chr 5, 37026360: 37026361
186NIPBLNM_133433.3(NIPBL): c.6108+2T> CSNVPathogenicrs797045775GRCh38Chr 5, 37038740: 37038740
187NIPBLNM_133433.3(NIPBL): c.6249+2dupduplicationPathogenicrs797045776GRCh38Chr 5, 37044489: 37044489
188NIPBLNM_015384.4(NIPBL): c.6707dupA (p.Asn2236Lysfs)duplicationPathogenicrs797045778GRCh37Chr 5, 37048721: 37048721
189NIPBLNM_133433.3(NIPBL): c.6800T> G (p.Met2267Arg)SNVLikely pathogenicrs797045779GRCh37Chr 5, 37049249: 37049249
190NIPBLNM_015384.4(NIPBL): c.6811dupT (p.Ser2271Phefs)duplicationPathogenicrs797045780GRCh38Chr 5, 37049158: 37049158
191NIPBLNM_015384.4(NIPBL): c.7301_7308delATCTAGCCins13 (p.?)indelPathogenicrs797045782GRCh37Chr 5, 37057325: 37057332
192NIPBLNM_015384.4(NIPBL): c.7816dupA (p.Ile2606Asnfs)duplicationPathogenicrs797045783GRCh38Chr 5, 37060974: 37060974
193NIPBLNM_015384.4(NIPBL): c.7841_7842dupTA (p.Val2615Terfs)duplicationPathogenicrs797045784GRCh38Chr 5, 37060999: 37061000
194NIPBLNM_015384.4(NIPBL): c.7912dupG (p.Glu2638Glyfs)duplicationPathogenicrs797045785GRCh38Chr 5, 37063841: 37063841
195NIPBLNM_015384.4(NIPBL): c.7913dupA (p.Val2639Glyfs)duplicationPathogenicrs797045786GRCh38Chr 5, 37063842: 37063842
196NIPBLNM_133433.3(NIPBL): c.8275_8276dupCT (p.Val2760Trpfs)duplicationPathogenicrs797045787GRCh38Chr 5, 37064752: 37064753
197NIPBLNM_133433.3(NIPBL): c.8296_8300delATTAAinsTT (p.Ile2766_Lys2767delinsLeu)indelLikely pathogenicrs797045788GRCh38Chr 5, 37064773: 37064777
198NIPBLNM_133433.3(NIPBL): c.8342_8348delCTAATAAinsATT (p.Ala2781Aspfs)indelPathogenicrs797045789GRCh38Chr 5, 37064819: 37064825
199NIPBLNM_015384.4(NIPBL): c.2T> A (p.Met1Lys)SNVPathogenicrs121918264GRCh37Chr 5, 36953800: 36953800
200NIPBLNM_015384.4(NIPBL): c.7289A> G (p.Tyr2430Cys)SNVPathogenicrs121918265GRCh37Chr 5, 37057313: 37057313
201NIPBLNIPBL, 1-BP DEL, 150GdeletionPathogenicChr na, -1: -1
202NIPBLNIPBL, 1-BP INS, 7306GinsertionPathogenicChr na, -1: -1
203NIPBLNIPBL, 1-BP INS, 1546GinsertionPathogenicChr na, -1: -1
204NIPBLNM_015384.4(NIPBL): c.3616_3618delATA (p.Ile1206del)deletionPathogenicrs121918266GRCh37Chr 5, 37001132: 37001134
205NIPBLNIPBL, 2-BP DEL, 2479AGdeletionPathogenicChr na, -1: -1
206NIPBLNM_133433.3(NIPBL): c.5167C> T (p.Arg1723Ter)SNVPathogenicrs121918267GRCh37Chr 5, 37020717: 37020717
207NIPBLNM_015384.4(NIPBL): c.3737C> G (p.Ala1246Gly)SNVPathogenicrs121918268GRCh37Chr 5, 37002836: 37002836
208NIPBLNIPBL, IVS45AS, G-C, -1SNVPathogenicChr na, -1: -1
209NIPBLNIPBL, IVS44DS, A-G, +4SNVPathogenicChr na, -1: -1
210NIPBLNM_133433.3(NIPBL): c.4606C> T (p.Arg1536Ter)SNVPathogenicrs121918269GRCh37Chr 5, 37014830: 37014830
211NIPBLNM_015384.4(NIPBL): c.-321_-320delCCinsAindelPathogenicrs724159980GRCh37Chr 5, 36877039: 36877040
212NIPBLNM_015384.4(NIPBL): c.7175G> A (p.Cys2392Tyr)SNVLikely pathogenicrs886042231GRCh37Chr 5, 37052580: 37052580
213NIPBLNM_133433.3(NIPBL): c.3855+2T> CSNVPathogenicrs886043046GRCh37Chr 5, 37003451: 37003451
214NIPBLNM_133433.3(NIPBL): c.592delC (p.His198Ilefs)deletionPathogenicrs886043629GRCh37Chr 5, 36962358: 36962358
215NIPBLNM_015384.4(NIPBL): c.6082C> T (p.Gln2028Ter)SNVPathogenicrs886044351GRCh37Chr 5, 37038814: 37038814
216NIPBLNM_015384.4(NIPBL): c.7150C> T (p.Gln2384Ter)SNVPathogenicGRCh38Chr 5, 37052453: 37052453
217NIPBLNM_015384.4(NIPBL): c.2479_2480delAG (p.Arg827Glyfs)deletionPathogenicrs398124465GRCh37Chr 5, 36985761: 36985762
218NIPBLNM_133433.3(NIPBL): c.2602C> T (p.Arg868Ter)SNVPathogenicrs398124466GRCh37Chr 5, 36985884: 36985884
219NIPBLNM_015384.4(NIPBL): c.2626dupG (p.Asp876Glyfs)duplicationPathogenicrs398124467GRCh37Chr 5, 36985908: 36985908
220NIPBLNM_015384.4(NIPBL): c.5440C> T (p.Arg1814Ter)SNVPathogenicrs80358362GRCh37Chr 5, 37022358: 37022358
221NIPBLNM_015384.4(NIPBL): c.7047T> G (p.Tyr2349Ter)SNVPathogenicrs398124470GRCh38Chr 5, 37051871: 37051871
222NIPBLNM_133433.3(NIPBL): c.7219C> T (p.Arg2407Ter)SNVPathogenicrs398124471GRCh37Chr 5, 37052624: 37052624
223NIPBLNM_133433.3(NIPBL): c.8377C> T (p.Arg2793Ter)SNVPathogenicrs398124474GRCh37Chr 5, 37064956: 37064956
224NIPBLNM_133433.3(NIPBL): c.133C> T (p.Arg45Ter)SNVPathogenicrs80358367GRCh37Chr 5, 36955642: 36955642
225NIPBLNM_015384.4(NIPBL): c.1445_1448delGAGA (p.Arg482Asnfs)deletionPathogenicrs80358382GRCh37Chr 5, 36976454: 36976457
226NIPBLNM_015384.4(NIPBL): c.192delG (p.Gln64Hisfs)deletionPathogenicrs80358364GRCh37Chr 5, 36955701: 36955701
227NIPBLNM_133433.3(NIPBL): c.3445C> T (p.Arg1149Ter)SNVPathogenicrs80358374GRCh37Chr 5, 37000615: 37000615
228NIPBLNM_015384.4(NIPBL): c.4285_4294delGAACTACAGT (p.Glu1429Cysfs)deletionPathogenicrs80358386GRCh37Chr 5, 37008155: 37008164
229NIPBLNM_133433.3(NIPBL): c.4511T> A (p.Leu1504Ter)SNVPathogenicrs80358369GRCh37Chr 5, 37010278: 37010278
230NIPBLNM_015384.4(NIPBL): c.4806_4807delGA (p.Glu1602Aspfs)deletionPathogenicrs80358372GRCh37Chr 5, 37017150: 37017151
231NIPBLNM_133433.3(NIPBL): c.5366G> A (p.Arg1789Gln)SNVLikely pathogenicrs80358380GRCh37Chr 5, 37022190: 37022190
232NIPBLNM_133433.3(NIPBL): c.5456G> A (p.Arg1819Gln)SNVLikely pathogenicrs80358366GRCh37Chr 5, 37022374: 37022374
233NIPBLNM_133433.3(NIPBL): c.5566A> G (p.Arg1856Gly)SNVLikely pathogenicrs80358373GRCh37Chr 5, 37022484: 37022484
234NIPBLNM_133433.3(NIPBL): c.585C> G (p.Tyr195Ter)SNVPathogenicrs80358360GRCh37Chr 5, 36962351: 36962351
235NIPBLNM_133433.3(NIPBL): c.6631G> T (p.Glu2211Ter)SNVPathogenicrs80358363GRCh37Chr 5, 37048645: 37048645
236NIPBLNM_015384.4(NIPBL): c.6641_6647delATCTATA (p.Asn2214Ilefs)deletionPathogenicrs80358361GRCh37Chr 5, 37048655: 37048661
237NIPBLNM_133433.3(NIPBL): c.6892C> G (p.Arg2298Gly)SNVPathogenicrs80358376GRCh37Chr 5, 37049341: 37049341
238NIPBLNM_133433.3(NIPBL): c.7301A> G (p.Asn2434Ser)SNVLikely pathogenicrs80358384GRCh37Chr 5, 37057325: 37057325
239NIPBLNM_133433.3(NIPBL): c.7327C> T (p.Gln2443Ter)SNVPathogenicrs80358370GRCh37Chr 5, 37057351: 37057351
240NIPBLNM_133433.3(NIPBL): c.7789delC (p.Leu2597Cysfs)deletionPathogenicrs80358368GRCh37Chr 5, 37061049: 37061049
241NIPBLNM_015384.4(NIPBL): c.7806dupT (p.Asn2603Terfs)duplicationPathogenicrs80358371GRCh37Chr 5, 37061066: 37061066

Copy number variations for Cornelia De Lange Syndrome 1 from CNVD:

6 (show all 12)
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
13920010111800000114900000Copy numberSMC3Cornelia de Lange syndrome
219907353440000038500000Copy numberNIPBLCornelia de Lange syndrome
330014010105700000119100000Missense,nonsense, small deletions and insertions, splice site mutations, and genomic rearrangementsHDAC8Cornelia de Lange syndrome
430014110105700000119100000Missense,nonsense, small deletions and insertions, splice site mutations, and genomic rearrangementsNIPBLCornelia de Lange syndrome
530014210105700000119100000Missense,nonsense, small deletions and insertions, splice site mutations, and genomic rearrangementsRAD21Cornelia de Lange syndrome
630014310105700000119100000Missense,nonsense, small deletions and insertions, splice site mutations, and genomic rearrangementsSMC1ACornelia de Lange syndrome
730014410105700000119100000Missense,nonsense, small deletions and insertions, splice site mutations, and genomic rearrangementsSMC3Cornelia de Lange syndrome
83045998117700000127300000Missense,nonsense, small deletions and insertions, splice site mutations, and genomic rearrangementsHDAC8Cornelia de Lange syndrome
93046008117700000127300000Missense,nonsense, small deletions and insertions, splice site mutations, and genomic rearrangementsNIPBLCornelia de Lange syndrome
103046018117700000127300000Missense,nonsense, small deletions and insertions, splice site mutations, and genomic rearrangementsRAD21Cornelia de Lange syndrome
113046028117700000127300000Missense,nonsense, small deletions and insertions, splice site mutations, and genomic rearrangementsSMC1ACornelia de Lange syndrome
123046038117700000127300000Missense,nonsense, small deletions and insertions, splice site mutations, and genomic rearrangementsSMC3Cornelia de Lange syndrome

Expression for genes affiliated with Cornelia De Lange Syndrome 1

About this section
Search GEO for disease gene expression data for Cornelia De Lange Syndrome 1.

Pathways for genes affiliated with Cornelia De Lange Syndrome 1

About this section

GO Terms for genes affiliated with Cornelia De Lange Syndrome 1

About this section

Cellular components related to Cornelia De Lange Syndrome 1 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MLL1 complexGO:007133911.0KMT2A, TAF6
2meiotic cohesin complexGO:003089311.0SMC1A, SMC3
3cohesin complexGO:000827810.9RAD21, SMC3
4nuclear meiotic cohesin complexGO:003499110.9RAD21, SMC3
5chromosomeGO:000569410.2PDS5A, RAD21, SMC1A, SMC3, STAG1
6SMC loading complexGO:003211610.1MAU2, NIPBL
7chromosome, centromeric regionGO:00007759.9CTCF, PDS5A, RAD21, SMC1A, SMC3, STAG1
8chromatinGO:00007859.8ESCO2, MAU2, NIPBL, PDS5A, RAD21, SMC3
9nucleoplasmGO:00056548.6CTCF, ESCO2, HDAC8, KMT2A, MAU2, NIPBL
10nucleusGO:00056347.7CTCF, ESCO2, HDAC8, KMT2A, MAU2, NIPBL

Biological processes related to Cornelia De Lange Syndrome 1 according to GeneCards Suite gene sharing:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1meiotic nuclear divisionGO:000712610.9SMC1A, SMC3
2negative regulation of DNA endoreduplicationGO:003287610.9SMC1A, SMC3
3embryonic digestive tract morphogenesisGO:004855710.9NIPBL, SHOX2
4maintenance of mitotic sister chromatid cohesionGO:003408810.9MAU2, NIPBL
5DNA methylationGO:000630610.8CTCF, KMT2A
6regulation of DNA replicationGO:000627510.8ESCO2, SMC3
7protein localization to chromatinGO:007116810.8ESCO2, RAD21
8regulation of chondrocyte differentiationGO:003233010.7SHOX2, TRPS1
9stem cell population maintenanceGO:001982710.6NIPBL, SMC1A, SMC3
10mitotic sister chromatid cohesionGO:000706410.4NIPBL, PDS5A, SMC1A, SMC3
11protein sumoylationGO:001692510.4RAD21, SMC1A, SMC3, STAG1
12negative regulation of transcription from RNA polymerase II promoterGO:00001229.9CTCF, HDAC8, NIPBL, SHOX2, SNCA, TRPS1
13cell divisionGO:00513019.9MAU2, PDS5A, RAD21, SMC1A, SMC3, STAG1
14sister chromatid cohesionGO:00070629.8HDAC8, PDS5A, RAD21, SMC1A, SMC3, STAG1
15positive regulation of transcription from RNA polymerase II promoterGO:00459449.7CTCF, KMT2A, NIPBL, RAD21, SHOX2, STAG1
16transcription from RNA polymerase II promoterGO:00063669.2CTCF, KMT2A, RAD21, STAG1, TAF6, TRPS1

Molecular functions related to Cornelia De Lange Syndrome 1 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1dynein bindingGO:004550210.6SMC3, SNCA
2mediator complex bindingGO:003603310.6NIPBL, SMC1A, SMC3
3protein N-terminus bindingGO:004748510.4MAU2, NIPBL, SNCA
4chromatin bindingGO:00036829.7CTCF, KMT2A, NIPBL, SMC1A, SMC3, STAG1
5transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific bindingGO:00012289.6CTCF, RAD21, STAG1, TRPS1

Sources for Cornelia De Lange Syndrome 1

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet